Texas Instruments (TXN) 10-K 14 Feb 25 2024 FY Annual report Financial data

Cover Page

Cover Page - USD ($)	12 Months Ended
	Dec. 31, 2024	Jan. 28, 2025	Jun. 30, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2024
Document Transition Report	false
Entity File Number	001-03761
Entity Registrant Name	TEXAS INSTRUMENTS INCORPORATED
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	75-0289970
Entity Address, Address Line One	12500 TI Boulevard
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75243
City Area Code	214
Local Phone Number	479-3773
Title of 12(b) Security	Common Stock, par value $1.00
Trading Symbol	TXN
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 177,352,918,130
Entity Common Stock, Shares Outstanding		910,332,971
Documents Incorporated by Reference	Part III hereof incorporates information by reference to the Registrant’s proxy statement for the 2025 annual meeting of stockholders.
Entity Central Index Key	0000097476
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Auditor [Abstract]
Auditor Name	Ernst & Young LLP
Auditor Firm ID	42
Auditor Location	Dallas, Texas

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue	$ 15,641	$ 17,519	$ 20,028
Cost of revenue (COR)	6,547	6,500	6,257
Gross profit	9,094	11,019	13,771
Research and development (R&D)	1,959	1,863	1,670
Selling, general and administrative (SG&A)	1,794	1,825	1,704
Restructuring charges/other	(124)	0	257
Operating profit	5,465	7,331	10,140
Other income (expense), net (OI&E)	496	440	106
Interest and debt expense	508	353	214
Income before income taxes	5,453	7,418	10,032
Provision for income taxes	654	908	1,283
Net income	$ 4,799	$ 6,510	$ 8,749
Earnings per common share (EPS):
Basic (in dollars per share)	$ 5.24	$ 7.13	$ 9.51
Diluted (in dollars per share)	$ 5.20	$ 7.07	$ 9.41
Average shares outstanding:
Basic (in shares)	912	908	916
Diluted (in shares)	919	916	926
Diluted EPS:
Net income	$ 4,799	$ 6,510	$ 8,749
Income allocated to RSUs	(24)	(33)	(39)
Income allocated to common stock for diluted EPS	$ 4,775	$ 6,477	$ 8,710

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 4,799	$ 6,510	$ 8,749
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($20), ($9) and $48	53	27	(155)
Recognized within net income, net of tax effect of ($3), ($5) and ($17)	10	15	61
Prior service cost (credit) of defined benefit plans:
Recognized within net income, net of tax effect of $0, $0 and $0	1	1	(1)
Derivative instruments:
Change in fair value, net of tax effect of $0, $0 and $0	1	1	1
Available-for-sale investments:
Unrealized gains (losses), net of tax effect of $0, ($1) and $1	0	5	(3)
Other comprehensive income (loss), net of taxes	65	49	(97)
Total comprehensive income	$ 4,864	$ 6,559	$ 8,652

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income
Net actuarial losses of defined benefit plans adjustment, tax effect	$ (20)	$ (9)	$ 48
Net actuarial losses of defined benefit plans recognized within net income, tax effect	(3)	(5)	(17)
Prior service cost of defined benefit plans recognized within net income, tax effect	0	0	0
Derivative instruments change in fair value, tax effect	0	0	0
Available-for-sale investments unrealized losses, tax effect	$ 0	$ (1)	$ 1

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 3,200	$ 2,964
Short-term investments	4,380	5,611
Accounts receivable, net of allowances of ($21) and ($16)	1,719	1,787
Raw materials	395	420
Work in process	2,214	2,109
Finished goods	1,918	1,470
Inventories	4,527	3,999
Prepaid expenses and other current assets	1,200	761
Total current assets	15,026	15,122
Property, plant and equipment at cost	15,254	13,268
Accumulated depreciation	(3,907)	(3,269)
Property, plant and equipment	11,347	9,999
Goodwill	4,362	4,362
Deferred tax assets	936	757
Capitalized software licenses	257	223
Overfunded retirement plans	233	173
Other long-term assets	3,348	1,712
Total assets	35,509	32,348
Current liabilities:
Current portion of long-term debt	750	599
Accounts payable	820	802
Accrued compensation	839	836
Income taxes payable	159	172
Accrued expenses and other liabilities	1,075	911
Total current liabilities	3,643	3,320
Long-term debt	12,846	10,624
Underfunded retirement plans	110	108
Deferred tax liabilities	53	63
Other long-term liabilities	1,954	1,336
Total liabilities	18,606	15,451
Stockholders’ equity:
Preferred stock, $25 par value. Shares authorized – 10; none issued	0	0
Common stock, $1 par value. Shares authorized – 2,400; shares issued – 1,741	1,741	1,741
Paid-in capital	3,935	3,362
Retained earnings	52,262	52,283
Treasury common stock at cost Shares: 2024 - 830; 2023 - 832	(40,895)	(40,284)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(140)	(205)
Total stockholders’ equity	16,903	16,897
Total liabilities and stockholders’ equity	$ 35,509	$ 32,348

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Allowance for doubtful accounts receivable, current	$ (21)	$ (16)
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 25	$ 25
Preferred stock, shares authorized (in shares)	10	10
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	2,400	2,400
Common stock, shares issued (in shares)	1,741	1,741
Treasury stock (in shares)	830	832

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities
Net income		$ 4,799	$ 6,510	$ 8,749
Adjustments to net income:
Depreciation		1,508	1,175	925
Amortization of capitalized software		72	63	54
Stock compensation		387	362	289
Gains on sales of assets		(127)	0	(3)
Deferred taxes		(210)	(299)	(191)
Increase (decrease) from changes in:
Accounts receivable		68	108	(194)
Inventories		(528)	(1,242)	(847)
Prepaid expenses and other current assets		7	46	6
Accounts payable and accrued expenses		125	(33)	106
Accrued compensation		(12)	29	22
Income taxes payable		597	(7)	94
Changes in funded status of retirement plans		33	45	114
Other		(401)	(337)	(404)
Cash flows from operating activities		6,318	6,420	8,720
Cash flows from investing activities
Capital expenditures		(4,820)	(5,071)	(2,797)
Proceeds from asset sales		195	3	3
Purchases of short-term investments		(9,716)	(12,705)	(14,483)
Proceeds from short-term investments		11,187	13,387	13,657
Other		(48)	24	37
Cash flows from investing activities		(3,202)	(4,362)	(3,583)
Cash flows from financing activities
Proceeds from issuance of long-term debt		2,980	3,000	1,494
Repayment of debt		(600)	(500)	(500)
Dividends paid		(4,795)	(4,557)	(4,297)
Stock repurchases		(929)	(293)	(3,615)
Proceeds from common stock transactions	[1]	517	263	241
Other		(53)	(57)	(41)
Cash flows from financing activities		(2,880)	(2,144)	(6,718)
Net change in cash and cash equivalents		236	(86)	(1,581)
Cash and cash equivalents at beginning of period		2,964	3,050	4,631
Cash and cash equivalents at end of period		3,200	2,964	3,050
Supplemental cash flow information
Investment tax credit (ITC) used to reduce income taxes payable		588	0	0
Total cash benefit related to the U.S. CHIPS and Science Act		$ 588	$ 0	$ 0
[1] Net of taxes paid for employee shares withheld of $39 million, $46 million and $50 million in 2024, 2023 and 2022, respectively.

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions	Total	Common Stock	Paid-in Capital	Retained Earnings	Treasury Common Stock	AOCI
Balance, beginning balance at Dec. 31, 2021		$ 1,741	$ 2,630	$ 45,919	$ (36,800)	$ (157)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 8,749			8,749
Dividends declared and paid				(4,297)
Common stock issued for stock-based awards			35		206
Stock repurchases					(3,620)
Stock compensation			289
Other comprehensive income (loss), net of taxes	(97)					(97)
Dividend equivalents on RSUs				(18)
Other			(3)		0
Balance, ending balance at Dec. 31, 2022		1,741	2,951	50,353	(40,214)	(254)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	6,510			6,510
Dividends declared and paid				(4,557)
Common stock issued for stock-based awards			50		213
Stock repurchases					(283)
Stock compensation			362
Other comprehensive income (loss), net of taxes	49					49
Dividend equivalents on RSUs				(23)
Other			(1)
Balance, ending balance at Dec. 31, 2023	16,897	1,741	3,362	52,283	(40,284)	(205)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	4,799			4,799
Dividends declared and paid				(4,795)
Common stock issued for stock-based awards			188		329
Stock repurchases					(940)
Stock compensation			387
Other comprehensive income (loss), net of taxes	65					65
Dividend equivalents on RSUs				(25)
Other			(2)
Balance, ending balance at Dec. 31, 2024	$ 16,903	$ 1,741	$ 3,935	$ 52,262	$ (40,895)	$ (140)

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]
Cash dividends declared per common share (in dollars per share)	$ 5.26	$ 5.02	$ 4.69
Cash dividends paid per common share (in dollars per share)	$ 5.26	$ 5.02	$ 4.69

Description of Business, Includ

Description of Business, Including Segment and Geographic Area Information	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Description of business, including segment and geographic area information	Description of business, including segment and geographic area information We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. We have two reportable segments, Analog and Embedded Processing, each of which represents groups of products that have similar design and development requirements, product characteristics and manufacturing processes. Our segments reflect how our chief operating decision maker (CODM), which is our chief executive officer, allocates resources and measures results. • Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing, discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog segment consists of two major product lines: Power and Signal Chain. • Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific tasks and can be optimized for various combinations of performance, power and cost, depending on the application. We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP ® products, calculators and custom ASIC products. In Other, we also include items that are not used in evaluating the results of or in allocating resources to our segments. Examples of these items include acquisition, integration and restructuring charges (see Note 11); and certain corporate-level items, such as litigation expenses, environmental costs, insurance settlements, and gains and losses from other activities, including asset dispositions. We allocate the remainder of our expenses associated with corporate activities to our operating segments based on specific methodologies, such as percentage of operating expenses or headcount. Our centralized manufacturing and support organizations, such as facilities, procurement and logistics, provide support to our operating segments, including those in Other. Costs incurred by these organizations, including depreciation, are charged to the segments on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the segments’ results and, therefore, is not provided. With the exception of goodwill, we do not identify or allocate assets by operating segment, nor does the CODM evaluate operating segments using discrete asset information. We have no material intersegment revenue. The accounting policies of the segments are consistent with those described in the significant accounting policies and practices. The CODM assesses the performance of our segments and decides how to allocate resources based on each segment’s revenue growth, gross margin and operating profit. The CODM utilizes these metrics by comparing budget versus actual results as well as benchmarking to our competitors. Segment information For Year Ended December 31, 2024 Analog Embedded Processing Other Total Revenue $ 12,161 $ 2,533 $ 947 $ 15,641 Cost of revenue 4,869 1,315 363 6,547 Gross profit 7,292 1,218 584 9,094 Research and development 1,411 475 73 1,959 Selling, general and administrative 1,273 391 130 1,794 Restructuring charges/other — — (124) (124) Operating profit $ 4,608 $ 352 $ 505 $ 5,465 For Year Ended December 31, 2023 Analog Embedded Processing Other Total Revenue $ 13,040 $ 3,368 $ 1,111 $ 17,519 Cost of revenue 4,615 1,493 392 6,500 Gross profit 8,425 1,875 719 11,019 Research and development 1,317 457 89 1,863 Selling, general and administrative 1,287 410 128 1,825 Restructuring charges/other — — — — Operating profit $ 5,821 $ 1,008 $ 502 $ 7,331 For Year Ended December 31, 2022 Analog Embedded Processing Other Total Revenue $ 15,359 $ 3,261 $ 1,408 $ 20,028 Cost of revenue 4,610 1,223 424 6,257 Gross profit 10,749 2,038 984 13,771 Research and development 1,178 413 79 1,670 Selling, general and administrative 1,212 372 120 1,704 Restructuring charges/other — — 257 257 Operating profit $ 8,359 $ 1,253 $ 528 $ 10,140 Geographic area information Our estimate for revenue based on the geographic location of our end customers’ headquarters, which represents where critical decisions are made, is as follows: For Years Ended December 31, 2024 2023 2022 Revenue: United States $ 5,957 38 % $ 5,814 33 % $ 6,609 33 % China 3,012 19 3,293 19 4,807 24 Rest of Asia 1,681 11 1,721 10 2,003 10 Europe, Middle East and Africa (a) 3,519 22 4,642 26 4,807 24 Japan 1,212 8 1,782 10 1,602 8 Rest of world 260 2 267 2 200 1 Total revenue $ 15,641 100 % $ 17,519 100 % $ 20,028 100 % (a) Revenue from end customers headquartered in Germany was 11%, 13% and 11% of total revenue in 2024, 2023 and 2022, respectively. Property, plant and equipment by geographic area, based on physical location: December 31, 2024 2023 Property, plant and equipment: United States $ 8,342 $ 7,548 China 737 731 Rest of Asia 1,877 1,433 Europe, Middle East and Africa 74 68 Japan 274 169 Rest of world 43 50 Total property, plant and equipment $ 11,347 $ 9,999 Major customer One of our end customers accounted for 12% of revenue in 2024 recognized primarily in our Analog segment. No end customer accounted for 10% or more of revenue in 2023 or 2022.

Basis of Presentation and Signi

Basis of Presentation and Significant Accounting Policies and Practices	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation and significant accounting policies and practices	Basis of presentation and significant accounting policies and practices Basis of presentation The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP). The basis of these financial statements is comparable for all periods presented herein. The consolidated financial statements include the accounts of all subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. All dollar and share amounts in the financial statements and tables in these notes, except per-share amounts, are presented in millions unless otherwise indicated. We have reclassified certain amounts in the prior periods’ financial statements to conform to the 2024 presentation. The preparation of financial statements requires the use of estimates from which final results may vary. Significant accounting policies and practices Revenue recognition We generate revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, and recognize revenue when control is transferred. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where required, when the customer has accepted the products. This transfer generally occurs at a point in time upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Payment for sales to customers and distributors is generally due on our standard commercial terms. For sales to distributors, payment is not contingent upon resale of the products. Revenue from sales of our products that are subject to inventory consignment agreements is recognized at a point in time, when the customer or distributor pulls product from consignment inventory that we store at designated locations. Delivery and transfer of control occur at that point, when title and risk of loss transfers and the customer or distributor becomes obligated to pay for the products pulled from inventory. Until the products are pulled for use or sale by the customer or distributor, we retain control over the products’ disposition, including the right to pull back or relocate the products. The revenue recognized is adjusted based on allowances, which are prepared on a portfolio basis using a most likely amount methodology based on analysis of historical data and contractual terms. These allowances, which are not material, generally include adjustments for pricing arrangements, product returns and incentives. We recognize shipping fees received from customers, if any, in revenue. We include the related shipping and handling costs in cost of revenue. The majority of our customers pay these fees directly to third parties. Advertising costs We expense advertising and other promotional costs as incurred. This expense was $30 million, $28 million and $27 million in 2024, 2023 and 2022, respectively. Income taxes We account for income taxes using an asset and liability approach. We record the amount of taxes payable or refundable for the current year and the deferred tax assets and liabilities for future tax consequences related to events that have been recognized in the financial statements or tax returns. We record a valuation allowance when it is more likely than not that some or all of the deferred tax assets will not be realized. Other assessed taxes Some transactions require us to collect taxes such as sales, value-added and excise taxes from our customers. These transactions are presented in our Consolidated Statements of Income on a net (excluded from revenue) basis. Leases We determine if an arrangement is a lease at inception. Leases are included in other long-term assets, accrued expenses and other liabilities, and other long-term liabilities on our Consolidated Balance Sheets. Lease assets represent our right to use underlying assets for the lease term, and lease liabilities represent our obligations to make lease payments over the lease term. On the commencement date, leases are evaluated for classification, and assets and liabilities are recognized based on the present value of lease payments over the lease term. We use our incremental borrowing rate based on the information available at commencement in determining the present value of lease payments. Operating lease expense is generally recognized on a straight-line basis over the lease term. Our lease values include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. We have agreements with lease and non-lease components, which are accounted for as a single lease component. Leases with an initial lease term of 12 months or less are not recorded on the balance sheet. Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing nonforfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock. Computation and reconciliation of earnings per common share are as follows: For Years Ended December 31, 2024 2023 2022 Net Income Shares EPS Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 4,799 $ 6,510 $ 8,749 Income allocated to RSUs (24) (34) (40) Income allocated to common stock $ 4,775 912 $ 5.24 $ 6,476 908 $ 7.13 $ 8,709 916 $ 9.51 Dilutive effect of stock compensation plans 7 8 10 Diluted EPS: Net income $ 4,799 $ 6,510 $ 8,749 Income allocated to RSUs (24) (33) (39) Income allocated to common stock $ 4,775 919 $ 5.20 $ 6,477 916 $ 7.07 $ 8,710 926 $ 9.41 Potentially dilutive securities representing 8 million, 10 million and 5 million shares of common stock that were outstanding in 2024, 2023 and 2022, respectively, were excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-dilutive. Investments We present investments on our Consolidated Balance Sheets as cash equivalents, short-term investments or other long-term assets. See Note 6 for additional information. • Cash equivalents and short-term investments – The primary objectives of our cash equivalent and short-term investment activities are to preserve capital and maintain liquidity while generating appropriate returns. We consider investments in available-for-sale debt securities with maturities of 90 days or less from the date of our investment to be cash equivalents. We consider investments in available-for-sale debt securities with maturities beyond 90 days from the date of our investment as being available for use in current operations and include them in short-term investments. • Other long-term assets – Long-term investments, which are included within other long-term assets on our Consolidated Balance Sheets, consist of mutual funds, venture capital funds and nonmarketable securities. Inventories Inventories are stated at the lower of cost or estimated net realizable value. Cost is generally computed on a currently adjusted standard cost basis, which approximates cost on a first-in, first-out basis. Standard cost is based on the normal utilization of installed factory capacity. Cost associated with underutilization of capacity is expensed as incurred. Inventory held at consignment locations is included in our finished goods inventory. We review inventory quarterly for salability and obsolescence. A statistical allowance is provided for inventory considered unlikely to be sold. The statistical allowance is based on an analysis of historical disposal activity, historical customer shipments and age of inventory. A specific allowance for each material type will be carried if there is a significant event not captured by the statistical allowance. We write off inventory in the period in which disposal occurs. Government incentives Incentives provided by government entities are recognized when we have reasonable assurance that we will comply with the conditions of the incentive, if any, and the incentive will be received. Incentives, which include non-income tax incentives, related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and reduce depreciation expense over the useful lives of the assets. Incentives for specific operating activities are offset against the related expense in the period the expense is incurred. The U.S. CHIPS and Science Act (CHIPS Act) provides funding for manufacturing grants and research investments, and it establishes a 25% investment tax credit (ITC) for certain investments in U.S. semiconductor manufacturing. We expect to benefit from the ITC on qualifying manufacturing investments through 2034. We have also entered into an agreement with the U.S. Department of Commerce to receive direct funding of up to $1.6 billion for our three large-scale 300mm wafer fabs currently under construction in Sherman, Texas, and Lehi, Utah. Direct funding of the award will be based on the achievement of certain milestones. The agreement contains representations, warranties and covenants that relate to compliance with requirements for awards provided for in the CHIPS Act. In addition, the agreement includes certain events of default and related rights and remedies, including clawbacks. As of December 31, 2024, we have recognized $3.15 billion of CHIPS Act receivables, which are comprised of $904 million in prepaid expenses and other current assets and $2.25 billion in other long-term assets other long-term liabilities In 2024, the total cash benefit related to the ITC was $588 million, which was used to reduce our income taxes payable. The CHIPS Act ITC and direct funding incentives have reduced the carrying amounts of manufacturing assets Cost of revenue Property, plant and equipment and other capitalized costs Property, plant and equipment are stated at cost and depreciated over their estimated useful lives using the straight-line method. Our cost basis includes certain assets acquired in business combinations that were initially recorded at fair value as of the date of acquisition. Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements. We amortize acquisition-related intangibles on a straight-line basis over the estimated economic life of the assets. Capitalized software licenses are generally amortized on a straight-line basis over the term of the license. Fully depreciated or amortized assets are written off against accumulated depreciation or amortization. Impairments of long-lived assets We regularly review whether facts or circumstances exist that indicate the carrying values of property, plant and equipment or other long-lived assets, including intangible assets, are impaired. We assess the recoverability of assets by comparing the projected undiscounted net cash flows associated with those assets to their respective carrying amounts. Any impairment charge is based on the excess of the carrying amount over the fair value of those assets. Fair value is determined by available market valuations, if applicable, or by discounted cash flows. Goodwill Goodwill is reviewed for impairment annually in the fourth quarter or more frequently if certain impairment indicators arise. We perform a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. If we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying value, or if we elect not to use a qualitative assessment, then we perform a quantitative goodwill impairment test. See Note 11 for additional information. Foreign currency The functional currency for our non-U.S. subsidiaries is the U.S. dollar. Accounts recorded in currencies other than the U.S. dollar are remeasured into the functional currency. Current assets (except inventories), deferred taxes, current liabilities and long-term liabilities are remeasured at exchange rates in effect at the end of each reporting period. Property, plant and equipment with associated depreciation and inventories are valued at historical exchange rates. Revenue and expense accounts other than depreciation for each month are calculated at the appropriate daily rate of exchange. Currency exchange gains and losses from remeasurement are credited or charged to OI&E. Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions were not material. We do not use derivatives for speculative or trading purposes.

Stock Compensation

Stock Compensation	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock compensation	Stock compensation We have stock options outstanding to participants under long-term incentive plans. The option price per share may not be less than the fair market value of our common stock on the date of the grant. The options have a 10-year term, generally vest ratably over four years and continue to vest after the option recipient retires. We also have RSUs outstanding to participants under long-term incentive plans. Each RSU represents the right to receive one share of TI common stock, issued on the vesting date, which is generally four years after the date of grant. RSUs continue to vest after the recipient retires. Holders of RSUs receive an annual cash payment equivalent to the dividends paid on our common stock. The fair value per share of RSUs is generally determined based on the closing price of our common stock on the date of grant. We have options and RSUs outstanding to non-employee directors under director compensation plans. The plans generally provide for annual grants of stock options and RSUs, a one-time grant of RSUs to each new non-employee director and the issuance of TI common stock upon the distribution of stock units credited to director deferred compensation accounts. We also have an employee stock purchase plan (ESPP) under which options are offered to all eligible employees in amounts based on a percentage of the employee’s compensation, subject to a cap. Under the plan, the option price per share is 85% of the fair market value on the exercise date. As of December 31, 2024, 31 million shares remain available for future issuance under this plan. Total stock compensation expense recognized is as follows: For Years Ended December 31, 2024 2023 2022 COR $ 52 $ 44 $ 34 R&D 132 119 90 SG&A 203 199 165 Total $ 387 $ 362 $ 289 These amounts include expenses related to non-qualified stock options, RSUs and stock options offered under our ESPP and are net of estimated forfeitures. We recognize compensation expense for non-qualified stock options and RSUs on a straight-line basis over the minimum service period required for vesting of the award, adjusting for estimated forfeitures based on historical activity. Awards issued to employees who are retirement eligible or nearing retirement eligibility are expensed on an accelerated basis. Options issued under our ESPP are expensed over a three-month period. As of December 31, 2024, total future compensation related to equity awards not yet recognized in our Consolidated Statements of Income was $503 million, which we expect to recognize over a weighted average period of 1.7 years. Fair value methods and assumptions We account for all awards granted under our various stock compensation plans at fair value. We estimate the fair values for non-qualified stock options using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions: For Years Ended December 31, 2024 2023 2022 Weighted average grant date fair value, per share $ 37.58 $ 46.23 $ 39.94 Weighted average assumptions used: Expected volatility 27 % 31 % 29 % Expected lives (in years) 5.6 6.1 6.4 Risk-free interest rates 4.04 % 3.60 % 1.83 % Expected dividend yields 3.11 % 2.86 % 2.64 % We use market-based measures of implied volatility to determine expected volatility on all options granted. We determine expected lives of options based on the historical option exercise experience of our option holders using a rolling 10-year average. Expected dividend yields are based on the annualized approved quarterly dividend rate and the current market price of our common stock at the time of grant. No assumption for a future dividend rate change is included unless there is an approved plan to change the dividend in the near term. Long-term incentive and director compensation plans Stock option and RSU transactions under our long-term incentive and director compensation plans are as follows: Stock Options RSUs Shares Weighted Average Exercise Price per Share Shares Weighted Average Grant Date Fair Value per Share Outstanding grants, December 31, 2023 26 $ 119.60 5 $ 161.40 Granted 5 $ 167.68 2 $ 173.59 Stock options exercised/RSUs vested (6) $ 82.42 (1) $ 131.82 Outstanding grants, December 31, 2024 (a) 25 $ 136.87 6 $ 168.68 (a) Forfeited and expired shares were not material. For Years Ended December 31, 2024 2023 2022 Weighted average grant date fair value per share for RSUs $ 173.59 $ 172.59 $ 174.39 Total grant date fair value of shares vested for RSUs $ 113 $ 106 $ 121 Aggregate intrinsic value of options exercised $ 597 $ 319 $ 336 As of December 31, 2024, 35 million shares remain available for future issuance under these plans. Summarized information about stock options outstanding as of December 31, 2024, is as follows: Exercise Price Range Number Outstanding (Shares) Weighted Average Remaining Contractual Life (Years) $49.03 to $206.61 25 5.7 Options Fully Vested and Expected to Vest (a) Options Exercisable Stock options outstanding (shares) 24 15 Weighted average remaining contractual life (in years) 5.7 4.0 Weighted average exercise price per share $ 136.44 $ 114.61 Intrinsic value (billions) $ 1.24 $ 1.08 (a) Includes effects of expected forfeitures. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $1.24 billion. Effect on shares outstanding and treasury shares Treasury shares were acquired in connection with the board-authorized stock repurchase program. As of December 31, 2024, $20.26 billion of stock repurchase authorizations remain, and no expiration date has been specified. Our practice is to issue shares of common stock from treasury shares upon exercise of stock options, distribution of director deferred compensation and vesting of RSUs. The following table reflects the changes in our treasury shares: For Years Ended December 31, 2024 2023 2022 Balance, January 1 832 835 817 Repurchases 5 2 22 Shares issued (7) (5) (4) Balance, December 31 830 832 835 The effects on cash flows are as follows: For Years Ended December 31, 2024 2023 2022 Proceeds from common stock transactions (a) $ 517 $ 263 $ 241 Tax benefit realized from stock compensation $ 158 $ 104 $ 110 (a) Net of taxes paid for employee shares withheld of $39 million, $46 million and $50 million in 2024, 2023 and 2022, respectively.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income taxes	Income taxes Income before income taxes is comprised of the following components: For Years Ended December 31, 2024 2023 2022 U.S. $ 4,438 $ 6,445 $ 9,122 Non-U.S. 1,015 973 910 Total $ 5,453 $ 7,418 $ 10,032 Provision for income taxes is comprised of the following components: For Years Ended December 31, 2024 2023 2022 Current Deferred Total Current Deferred Total Current Deferred Total U.S. federal $ 605 $ (139) $ 466 $ 943 $ (277) $ 666 $ 1,235 $ (223) $ 1,012 Non-U.S. 244 (71) 173 240 (22) 218 212 32 244 U.S. state 15 — 15 24 — 24 27 — 27 Total $ 864 $ (210) $ 654 $ 1,207 $ (299) $ 908 $ 1,474 $ (191) $ 1,283 Principal reconciling items from the U.S. statutory income tax rate to the effective tax rate (provision for income taxes as a percentage of income before income taxes) are as follows: For Years Ended December 31, 2024 2023 2022 U.S. statutory income tax rate 21.0 % 21.0 % 21.0 % Foreign derived intangible income (6.1) (6.8) (7.0) Stock compensation (2.1) (1.0) (0.7) R&D tax credit (2.0) (1.3) (0.9) Changes in uncertain tax positions 0.1 — 0.1 Other 1.1 0.3 0.3 Effective tax rate 12.0 % 12.2 % 12.8 % The earnings represented by non-cash operating assets, such as fixed assets and inventory, will continue to be permanently reinvested outside the United States. Provisions of the U.S. Tax Cuts and Jobs Act, such as the one-time tax on indefinitely reinvested earnings and the global intangible low-taxed income (GILTI) tax for years beginning in 2018, eliminate any additional U.S. taxation resulting from repatriation of earnings of non-U.S. subsidiaries to the United States. Consequently, no U.S. tax provision has been made for the future remittance of these earnings. However, withholding or distribution taxes in certain non-U.S. jurisdictions will be incurred upon repatriation of available cash to the United States. A provision has been made for deferred taxes on these undistributed earnings to the extent that repatriation of the available cash to the United States is expected to result in a tax liability. As of December 31, 2024, we have no basis differences that would result in material unrecognized deferred tax liabilities. We have made an allowable policy election to account for the effects of GILTI as a component of income tax expense in the period in which the tax is incurred. The primary components of deferred tax assets and liabilities are as follows: December 31, 2024 2023 Deferred tax assets: Capitalized R&D $ 1,076 $ 750 Accrued expenses 297 236 Deferred loss and tax credit carryforwards 216 205 Stock compensation 186 163 Inventories 105 104 Retirement costs for defined benefit and retiree health care 17 37 Other 23 47 Total deferred tax assets, before valuation allowance 1,920 1,542 Valuation allowance (212) (198) Total deferred tax assets, after valuation allowance 1,708 1,344 Deferred tax liabilities: Property, plant and equipment (441) (592) CHIPS Act incentives (336) — International earnings (33) (33) Acquisition-related intangibles and fair-value adjustments (6) (14) Other (9) (11) Total deferred tax liabilities (825) (650) Net deferred tax asset $ 883 $ 694 The deferred tax assets and liabilities based on tax jurisdictions are presented on our Consolidated Balance Sheets as follows: December 31, 2024 2023 Deferred tax assets $ 936 $ 757 Deferred tax liabilities (53) (63) Net deferred tax asset $ 883 $ 694 We make an ongoing assessment regarding the realization of U.S. and non-U.S. deferred tax assets. This assessment is based on our evaluation of relevant criteria, including the existence of deferred tax liabilities that can be used to absorb deferred tax assets, taxable income in prior carryback years and expectations for future taxable income. Valuation allowances increased $14 million, $9 million and $1 million in 2024, 2023 and 2022, respectively. These changes had no impact to net income in 2024, 2023 or 2022. We have no material tax loss carryforwards as of December 31, 2024. Cash payments made for income taxes, net of refunds, were $451 million, $1.35 billion and $1.48 billion in 2024, 2023 and 2022, respectively. In 2024, the total cash benefit related to the CHIPS Act ITC was $588 million, which was used to reduce our income taxes payable. Uncertain tax positions We operate in a number of tax jurisdictions, and our income tax returns are subject to examination by tax authorities in those jurisdictions who may challenge any item on these tax returns. Because the matters challenged by authorities are typically complex, their ultimate outcome is uncertain. Before any benefit can be recorded in our financial statements, we must determine that it is “more likely than not” that a tax position will be sustained by the appropriate tax authorities. We recognize accrued interest related to uncertain tax positions and penalties as components of OI&E. The changes in the total amounts of uncertain tax positions are as follows: 2024 2023 2022 Balance, January 1 $ 82 $ 82 $ 69 Additions based on tax positions related to the current year 3 3 3 Additions for tax positions of prior years — — 10 Reductions for tax positions of prior years — (3) — Balance, December 31 $ 85 $ 82 $ 82 Interest expense recognized in the year ended December 31 $ (5) $ (9) $ (1) Interest payable as of December 31 $ 15 $ 10 $ 3 The liability for uncertain tax positions is a component of other long-term liabilities on our Consolidated Balance Sheets. All of the $85 million and $82 million liabilities for uncertain tax positions as of December 31, 2024 and 2023, respectively, are comprised of positions that, if recognized, would lower the effective tax rate. If these liabilities are ultimately realized, no existing deferred tax assets in 2024 or 2023 would also be realized. As of December 31, 2024, the statute of limitations remains open for U.S. federal tax returns for 2018 and following years. Certain tax treaty procedures for relief from double taxation remain pending for U.S. federal tax returns for the years 2018 through 2022. In non-U.S. jurisdictions, the years open to audit represent the years still open under the statute of limitations. With respect to major jurisdictions outside the United States, our subsidiaries are no longer subject to income tax audits for years before 2012.

Financial Instruments and Risk

Financial Instruments and Risk Concentration	12 Months Ended
	Dec. 31, 2024
Risks and Uncertainties [Abstract]
Financial instruments and risk concentration	Financial instruments and risk concentration Financial instruments We hold derivative financial instruments such as forward foreign currency exchange contracts, the fair value of which was not material as of December 31, 2024. Our forward foreign currency exchange contracts outstanding as of December 31, 2024, had a notional value of $565 million to hedge our non-U.S. dollar net balance sheet exposures, including $180 million to buy Indian rupee, $91 million to sell British pounds and $78 million to sell Japanese yen. Our investments in cash equivalents, short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. Our postretirement plan assets are carried at fair value or net asset value per share. The carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value due to the short maturity of such instruments. As of December 31, 2024, the carrying value of long-term debt, including the current portion, was $13.60 billion, and the estimated fair value was $12.48 billion. The estimated fair value is measured using broker-dealer quotes, which are Level 2 inputs. See Note 6 for a description of fair value and the definition of Level 2 inputs. Risk concentration We are subject to counterparty risks from financial institutions, customers and issuers of debt securities. Financial instruments that could subject us to concentrations of credit risk are primarily cash deposits, cash equivalents, short-term investments and accounts receivable. To manage our credit risk exposure, we place cash investments in investment-grade debt securities and limit the amount of credit exposure to any one issuer. We also limit counterparties on cash deposits and financial derivative contracts to financial institutions with investment-grade ratings. Concentrations of credit risk with respect to accounts receivable are limited due to our large number of customers and their dispersion across different industries and geographic areas. We maintain allowances for expected returns, disputes, adjustments, incentives and credit losses. These allowances are deducted from accounts receivable on our Consolidated Balance Sheets. Accounts receivable allowances changed to reflect amounts charged to operating results by $5 million, $3 million and $5 million in 2024, 2023 and 2022, respectively.

Valuation of Debt and Equity In

Valuation of Debt and Equity Investments and Certain Liabilities	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Valuation of debt and equity investments and certain liabilities	Valuation of debt and equity investments and certain liabilities Investments measured at fair value Money market funds, debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. We classify all debt investments as available-for-sale. See Fair-value considerations. Unrealized gains and losses are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and nonmarketable investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other nonmarketable securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results. Nonmarketable securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on nonmarketable investments are recognized in OI&E. Details of our investments are as follows: December 31, 2024 December 31, 2023 Cash and Cash Equivalents Short-Term Investments Long-Term Investments Cash and Cash Equivalents Short-Term Investments Long-Term Investments Measured at fair value: Money market funds $ 762 $ — $ — $ 1,068 $ — $ — Corporate obligations 694 796 — 349 1,605 — U.S. government and agency securities 752 3,485 — 696 3,808 — Non-U.S. government and agency securities 249 99 — 50 198 — Mutual funds — — 11 — — 12 Total 2,457 4,380 11 2,163 5,611 12 Other measurement basis: Equity-method investments — — 8 — — 17 Nonmarketable investments — — 4 — — 5 Total — — 12 — — 22 Cash on hand 743 — — 801 — — Total $ 3,200 $ 4,380 $ 23 $ 2,964 $ 5,611 $ 34 As of December 31, 2024 and 2023, unrealized gains and losses associated with our debt investments were not material. We did not recognize any credit losses related to debt investments in 2024, 2023 or 2022. The following table presents the aggregate maturities of our debt investments as of December 31, 2024: Fair Value One year or less $ 5,348 One to two years 727 In 2024, 2023 and 2022, the proceeds from sales, redemptions and maturities of short-term debt investments were $11.19 billion, $13.39 billion and $13.66 billion, respectively. Gross realized gains and losses from these sales were not material. Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the inputs used to estimate fair-value measurements. • Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the measurement date. • Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the measurement date through correlation with market data. Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active and models or other pricing methodologies that do not require significant judgment. We utilize a third-party data service to provide Level 2 valuations, and we verify these valuations for reasonableness. • Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. As of December 31, 2024 and 2023, we had no Level 3 assets or liabilities. The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value. December 31, 2024 December 31, 2023 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Money market funds $ 762 $ — $ 762 $ 1,068 $ — $ 1,068 Corporate obligations — 1,490 1,490 — 1,954 1,954 U.S. government and agency securities 2,591 1,646 4,237 3,618 886 4,504 Non-U.S. government and agency securities — 348 348 — 248 248 Mutual funds 11 — 11 12 — 12 Total assets $ 3,364 $ 3,484 $ 6,848 $ 4,698 $ 3,088 $ 7,786 Liabilities: Deferred compensation $ 443 $ — $ 443 $ 393 $ — $ 393 Total liabilities $ 443 $ — $ 443 $ 393 $ — $ 393

Postretirement Benefit Plans

Postretirement Benefit Plans	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Postretirement benefit plans	Postretirement benefit plans Plan descriptions We have various employee retirement plans, including defined contribution, defined benefit and retiree health care benefit plans. For qualifying employees, we offer deferred compensation arrangements. U.S. retirement plans Our principal retirement plans in the United States are a defined contribution plan, an enhanced defined contribution plan and qualified and non-qualified defined benefit pension plans. The defined benefit plans were closed to new participants in 1997, and then current participants were allowed to make a one-time election to continue accruing a benefit in the plans or to cease accruing a benefit and instead to participate in the enhanced defined contribution plan. Both defined contribution plans offer an employer-matching savings option that allows employees to make pretax and post-tax contributions to various investment choices. Employees who elected to continue accruing a benefit in the qualified defined benefit pension plans may also participate in the defined contribution plan, where employer-matching contributions are provided for up to 2% of the employee’s annual eligible earnings. Employees who elected not to continue accruing a benefit in the defined benefit pension plans and employees hired after November 1997 and through December 31, 2003, may participate in the enhanced defined contribution plan. This plan provides for a fixed employer contribution of 2% of the employee’s annual eligible earnings, plus an employer-matching contribution of up to 4% of the employee’s annual eligible earnings. Employees hired after December 31, 2003, do not receive the fixed employer contribution of 2% of the employee’s annual eligible earnings. As of December 31, 2024 and 2023, as a result of employees’ elections, TI’s U.S. defined contribution plans held shares of TI common stock totaling 5 million shares in both periods valued at $852 million and $873 million, respectively. Dividends paid on these shares in 2024 and 2023 were $26 million and $27 million, respectively. Effective April 1, 2016, the TI common stock fund was frozen to new contributions or transfers into the fund. Our aggregate expense for the U.S. defined contribution plans was $76 million, $75 million and $70 million in 2024, 2023 and 2022, respectively. The defined benefit pension plans include employees still accruing benefits, as well as employees and participants who no longer accrue service-related benefits, but instead, may participate in the enhanced defined contribution plan. Benefits under the qualified defined benefit pension plan are determined using a formula based on years of service and the highest five U.S. retiree health care benefit plan U.S. employees who meet eligibility requirements are offered medical coverage during retirement. We make a contribution toward the cost of those retiree medical benefits for certain retirees and their dependents. The contribution rates are based upon various factors, the most important of which are an employee’s date of hire, date of retirement, years of service and eligibility for Medicare benefits. The balance of the cost is borne by the plan’s participants. Employees hired after January 1, 2001, are responsible for the full cost of their medical benefits during retirement. Non-U.S. retirement plans We provide retirement coverage for non-U.S. employees, as required by local laws or to the extent we deem appropriate, through a number of defined benefit and defined contribution plans. Retirement benefits are generally based on an employee’s years of service and compensation. Funding requirements are determined on an individual country and plan basis and are subject to local country practices and market circumstances. As of December 31, 2024 and 2023, as a result of employees’ elections, TI’s non-U.S. defined contribution plans held TI common stock valued at $34 million in both periods. Dividends paid on these shares of TI common stock in 2024 and 2023 were not material. Effects on our Consolidated Statements of Income and Balance Sheets Expenses related to defined benefit and retiree health care benefit plans are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit 2024 2023 2022 2024 2023 2022 2024 2023 2022 Service cost $ 7 $ 8 $ 15 $ 1 $ 2 $ 3 $ 16 $ 16 $ 25 Interest cost 25 28 29 13 15 11 55 57 33 Expected return on plan assets (23) (23) (27) (16) (19) (12) (77) (63) (66) Amortization of prior service cost (credit) — — — — — (2) 1 1 1 Recognized net actuarial losses (gains) 4 6 3 (3) (5) — 11 12 1 Net periodic benefit costs (credits) 13 19 20 (5) (7) — 6 23 (6) Settlement losses 1 7 64 — — — — — 10 Total, including other postretirement losses (gains) $ 14 $ 26 $ 84 $ (5) $ (7) $ — $ 6 $ 23 $ 4 All defined benefit and retiree health care benefit plan expense components other than service cost are recognized in OI&E For the U.S. qualified pension and retiree health care plans, the expected return on plan assets component of net periodic benefit cost is based upon a market-related value of assets. In accordance with U.S. GAAP, the market-related value of assets is the fair value adjusted by a smoothing technique whereby certain gains and losses are phased in over a period of three years. Changes in the benefit obligations and plan assets for defined benefit and retiree health care benefit plans are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit 2024 2023 2024 2023 2024 2023 Change in plan benefit obligation Benefit obligation at beginning of year: $ 505 $ 521 $ 258 $ 274 $ 1,732 $ 1,667 Service cost 7 8 1 2 16 16 Interest cost 25 28 13 15 55 57 Participant contributions — — 13 14 1 1 Benefits paid (36) (13) (39) (41) (83) (77) Settlements (2) (40) — — (6) (6) Actuarial loss (gain) (6) 1 (12) (6) (106) 80 Effects of exchange rate changes — — — — (87) (6) Benefit obligation at end of year $ 493 $ 505 $ 234 $ 258 $ 1,522 $ 1,732 Change in plan assets Fair value of plan assets at beginning of year: $ 418 $ 421 $ 264 $ 280 $ 1,866 $ 1,822 Actual return on plan assets 18 47 9 29 27 137 Employer contributions (qualified plans) — — 1 1 2 2 Employer contributions (non-qualified plans) 2 3 — — — — Participant contributions — — 13 14 1 1 Benefits paid (36) (13) (39) (41) (83) (77) Settlements (2) (40) — — (6) (6) Effects of exchange rate changes — — — — (99) (13) Other — — — (19) — — Fair value of plan assets at end of year $ 400 $ 418 $ 248 $ 264 $ 1,708 $ 1,866 Funded status at end of year $ (93) $ (87) $ 14 $ 6 $ 186 $ 134 Changes in actuarial gains and losses in the projected benefit obligations are generally driven by discount rate movement. Amounts recognized on our Consolidated Balance Sheets as of December 31, are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit Total 2024 Overfunded retirement plans $ — $ 16 $ 217 $ 233 Accrued expenses and other liabilities & other long-term liabilities (10) — (6) (16) Underfunded retirement plans (83) (2) (25) (110) Funded status at end of 2024 $ (93) $ 14 $ 186 $ 107 2023 Overfunded retirement plans $ — $ 8 $ 165 $ 173 Accrued expenses and other liabilities & other long-term liabilities (5) — (7) (12) Underfunded retirement plans (82) (2) (24) (108) Funded status at end of 2023 $ (87) $ 6 $ 134 $ 53 Contributions to the plans meet or exceed all minimum funding requirements. We expect to contribute about $10 million to our retirement benefit plans in 2025. Accumulated benefit obligations, which are generally less than the projected benefit obligations as they exclude the impact of future salary increases, were $470 million and $480 million as of December 31, 2024 and 2023, respectively, for the U.S. defined benefit plans, and $1.47 billion and $1.67 billion as of December 31, 2024 and 2023, respectively, for the non-U.S. defined benefit plans. The change in AOCI is as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit Total Net Actuarial Loss Net Actuarial Gain Prior Service Cost Net Actuarial Loss Prior Service Credit Net Actuarial Loss Prior Service Credit AOCI balance, net of taxes, December 31, 2023 $ 62 $ (24) $ — $ 169 $ — $ 207 $ — Changes in AOCI by category: Adjustments (1) (5) — (67) — (73) — Recognized within net income (5) 3 — (11) (1) (13) (1) Tax effect 1 — — 22 — 23 — Total change to AOCI (5) (2) — (56) (1) (63) (1) AOCI balance, net of taxes, December 31, 2024 $ 57 $ (26) $ — $ 113 $ (1) $ 144 $ (1) Information on plan assets We report and measure the plan assets of our defined benefit pension and other postretirement plans at fair value. The tables below set forth the fair value of our plan assets using the same three-level hierarchy of fair-value inputs described in Note 6. December 31, 2024 Level 1 Level 2 Other (a) Total Assets of U.S. defined benefit plan: Fixed income securities and cash equivalents $ 92 $ 51 $ 101 $ 244 Equity securities — — 156 156 Total $ 92 $ 51 $ 257 $ 400 Assets of U.S. retiree health care plan: Fixed income securities and cash equivalents $ 2 $ — $ 196 $ 198 Equity securities — — 50 50 Total $ 2 $ — $ 246 $ 248 Assets of non-U.S. defined benefit plans: Fixed income securities and cash equivalents $ 15 $ 475 $ 820 $ 1,310 Equity securities 27 1 370 398 Total $ 42 $ 476 $ 1,190 $ 1,708 (a) Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents. December 31, 2023 Level 1 Level 2 Other (a) Total Assets of U.S. defined benefit plan: Fixed income securities and cash equivalents $ — $ — $ 272 $ 272 Equity securities — — 146 146 Total $ — $ — $ 418 $ 418 Assets of U.S. retiree health care plan: Fixed income securities and cash equivalents $ 4 $ — $ 206 $ 210 Equity securities — — 54 54 Total $ 4 $ — $ 260 $ 264 Assets of non-U.S. defined benefit plans: Fixed income securities and cash equivalents $ 49 $ 52 $ 1,343 $ 1,444 Equity securities 57 1 364 422 Total $ 106 $ 53 $ 1,707 $ 1,866 (a) Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents. The investments in our major benefit plans largely consist of low-cost, broad-market index funds to mitigate risks of concentration within market sectors. Our investment policy is designed to better match the interest rate sensitivity of the plan assets and liabilities. The appropriate mix of equity and bond investments is determined primarily through the use of detailed asset-liability modeling studies that look to balance the impact of changes in the discount rate against the need to provide asset growth to cover future service cost. Most of our plans around the world have a greater proportion of fixed income securities with return characteristics that are more closely aligned with changes in the liabilities caused by discount rate volatility. Assumptions and investment policies U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit 2024 2023 2024 2023 2024 2023 Weighted average assumptions used to determine benefit obligations: Discount rate 5.55% 5.20% 5.65% 5.17% 3.76% 3.28% Long-term pay progression 3.00% 3.00% n/a n/a 3.14% 3.12% Weighted average assumptions used to determine net periodic benefit cost: Discount rate 5.21% 5.67% 5.17% 5.68% 3.28% 3.45% Long-term rate of return on plan assets 6.10% 5.70% 6.00% 5.70% 4.28% 3.50% Long-term pay progression 3.00% 3.75% n/a n/a 3.12% 3.03% We utilize a variety of methods to select an appropriate discount rate depending on the depth of the corporate bond market in the country in which the benefit plan operates. In the United States, we use a settlement approach whereby a portfolio of bonds is selected from the universe of actively traded high-quality U.S. corporate bonds. The selected portfolio is designed to simulate a portfolio that would provide cash flows sufficient to pay the plan’s expected benefit payments when due. The resulting discount rate reflects the rate of return of the selected portfolio of bonds. For our non-U.S. locations with a sufficient number of actively traded high-quality bonds, an analysis is performed in which the projected cash flows from the defined benefit plans are discounted against a yield curve constructed with an appropriate universe of high-quality corporate bonds available in each country. In this manner, a present value is developed. The discount rate selected is the single equivalent rate that produces the same present value. For countries that lack a sufficient corporate bond market, a government bond index is used to establish the discount rate. Assumptions for the expected long-term rate of return on plan assets are based on future expectations for returns for each asset class and the effect of periodic target asset allocation rebalancing. We adjust the results for the payment of reasonable expenses of the plan from plan assets. We believe our assumptions are appropriate based on the investment mix and long-term nature of the plans’ investments. Assumptions used for the non-U.S. defined benefit plans reflect the different economic environments within the various countries. The target allocation ranges for the plans that hold a substantial majority of the defined benefit assets are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit Fixed income securities and cash equivalents 60% – 75% 75% – 85% 60% – 100% Equity securities 25% – 40% 15% – 25% 0% – 40% We rebalance the plans’ investments when they are outside the target allocation ranges. Weighted average asset allocations as of December 31 are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit 2024 2023 2024 2023 2024 2023 Fixed income securities and cash equivalents 61% 65% 80% 80% 77% 77% Equity securities 39% 35% 20% 20% 23% 23% None of the plan assets related to the defined benefit pension plans and retiree health care benefit plan are directly invested in TI common stock. The following assumed future benefit payments to plan participants in the next 10 years are used to measure our benefit obligations. Almost all of the payments, which may vary significantly from these assumptions, will be made from plan assets and not from company assets. 2025 2026 2027 2028 2029 2030 – 2034 U.S. Defined Benefit $ 80 $ 76 $ 67 $ 60 $ 54 $ 193 U.S. Retiree Health Care 25 24 23 21 21 92 Non-U.S. Defined Benefit 85 88 88 90 92 476 Assumed health care cost trend rates for the U.S. retiree health care benefit plan as of December 31 are as follows: 2024 2023 Assumed health care cost trend rate for next year 7.00% 7.00% Ultimate trend rate 5.00% 5.00% Year in which ultimate trend rate is reached 2033 2032 Deferred compensation plans We have deferred compensation plans that allow U.S. employees whose base salary and management responsibility exceed a certain level to defer receipt of a portion of their cash compensation. Payments under these plans are made based on the participant’s distribution election and plan balance. Participants can earn a return on their deferred compensation based on notional investments in the same investment funds that are offered in our defined contribution plans. As of December 31, 2024, our liability to participants of the deferred compensation plans was $443 million and is recorded in other long-term liabilities on our Consolidated Balance Sheets. This amount reflects the accumulated participant deferrals and earnings thereon as of that date. We utilize total return swaps and investments in mutual funds that serve as economic hedges of our exposure to changes in the fair value of these liabilities. We record changes in the fair value of the liability and the related total return swaps and mutual funds in SG&A, as discussed in Note 6. As of December 31, 2024, we held $11 million in mutual funds related to these plans that are recorded in long-term investments on our Consolidated Balance Sheets.

Debt and Lines of Credit

Debt and Lines of Credit	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Debt and lines of credit	Debt and lines of credit Short-term borrowings We maintain a line of credit to provide additional liquidity through bank loans and, if necessary, to support commercial paper borrowings. As of December 31, 2024, the aforementioned line of credit was a variable-rate, revolving credit facility from a consortium of investment-grade banks that allows us to borrow up to $1 billion until March 2025. The interest rate on borrowings under this credit facility, if drawn, is indexed to the applicable Term Secured Overnight Financing Rate (Term SOFR). As of December 31, 2024, our credit facility was undrawn, and we had no commercial paper outstanding. Long-term debt In February 2024, we issued five series of senior unsecured notes for an aggregate principal amount of $3.00 billion, consisting of $650 million of 4.60% notes due in 2027, $650 million of 4.60% notes due in 2029, $600 million of 4.85% notes due in 2034, $750 million of 5.15% notes due in 2054 and $350 million of 5.05% notes due in 2063. We incurred $16 million of issuance and other related costs. The proceeds of the offering were $2.98 billion, net of the original issuance discounts, which will be used for general corporate purposes. We retired $300 million of maturing debt in May 2024 and an additional $300 million in November 2024. In March 2023, we issued two series of senior unsecured notes for an aggregate principal amount of $1.40 billion, consisting of $750 million of 4.90% notes due in 2033 and $650 million of 5.00% notes due in 2053. We incurred $11 million of issuance and other related costs. The proceeds of the offering were $1.40 billion, net of the original issuance discounts, which will be used for general corporate purposes. In May 2023, we issued three series of senior unsecured notes for an aggregate principal amount of $1.60 billion, consisting of $200 million of 4.60% notes due in 2028, $200 million of 4.90% notes due in 2033 and $1.20 billion of 5.05% notes due in 2063. We incurred $7 million of issuance and other related costs. The proceeds of the offering were $1.60 billion, net of the original issuance discounts and premiums, which will be used for general corporate purposes. In May 2023, we retired $500 million of maturing debt. In April 2022, we retired $500 million of maturing debt. In August 2022, we issued two series of senior unsecured notes for an aggregate principal amount of $700 million, consisting of $400 million of 3.65% notes due in 2032 and $300 million of 4.10% notes due in 2052. We incurred $3 million of issuance and other related costs. The proceeds of the offering were $695 million, net of the original issuance discounts, which will be used for general corporate purposes. In November 2022, we issued two series of senior unsecured notes for an aggregate principal amount of $800 million, consisting of $300 million of 4.70% notes due in 2024 and $500 million of 4.60% notes due in 2028. We incurred $3 million of issuance and other related costs. The proceeds of the offering were $799 million, net of the original issuance discounts, which will be used for general corporate purposes. Long-term debt outstanding is as follows: December 31, 2024 2023 Notes due 2024 at 2.625% $ — $ 300 Notes due 2024 at 4.70% — 300 Notes due 2025 at 1.375% 750 750 Notes due 2026 at 1.125% 500 500 Notes due 2027 at 4.60% 650 — Notes due 2027 at 2.90% 500 500 Notes due 2028 at 4.60% 700 700 Notes due 2029 at 4.60% 650 — Notes due 2029 at 2.25% 750 750 Notes due 2030 at 1.75% 750 750 Notes due 2031 at 1.90% 500 500 Notes due 2032 at 3.65% 400 400 Notes due 2033 at 4.90% 950 950 Notes due 2034 at 4.85% 600 — Notes due 2039 at 3.875% 750 750 Notes due 2048 at 4.15% 1,500 1,500 Notes due 2051 at 2.70% 500 500 Notes due 2052 at 4.10% 300 300 Notes due 2053 at 5.00% 650 650 Notes due 2054 at 5.15% 750 — Notes due 2063 at 5.05% 1,550 1,200 Total debt 13,700 11,300 Net unamortized discounts, premiums and issuance costs (104) (77) Total debt, including net unamortized discounts, premiums and issuance costs 13,596 11,223 Current portion of long-term debt (750) (599) Long-term debt $ 12,846 $ 10,624 Interest and debt expense was $508 million, $353 million and $214 million in 2024, 2023 and 2022, respectively. This was net of the amortized discounts, premiums and issuance and other related costs. Cash payments for interest on long-term debt were $473 million, $321 million and $198 million in 2024, 2023 and 2022, respectively. Capitalized interest was $20 million, $11 million and $6 million in 2024, 2023 and 2022, respectively.

Leases

Leases	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Leases	Leases We conduct certain operations in leased facilities and also lease a portion of our data processing and other equipment. In addition, certain long-term supply agreements to purchase industrial gases are accounted for as operating leases. Lease agreements frequently include renewal provisions and require us to pay real estate taxes, insurance and maintenance costs. Our leases are included as a component of the following balance sheet lines: December 31, 2024 2023 Other long-term assets $ 786 $ 579 Accrued expenses and other liabilities $ 118 $ 88 Other long-term liabilities 663 478 Details of our operating leases are as follows: For Years Ended 2024 2023 2022 Lease cost related to lease liabilities $ 85 $ 73 $ 67 Variable lease cost 64 54 46 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for lease cost $ 65 $ 65 $ 61 Lease assets obtained in exchange for new lease liabilities $ 241 $ 285 $ 37 As of December 31, 2024, we had committed to make the following minimum payments under our noncancelable operating leases: 2025 2026 2027 2028 2029 Thereafter Total Lease payments $ 121 $ 114 $ 103 $ 92 $ 80 $ 489 $ 999 Imputed lease interest (218) Total lease liabilities $ 781 The weighted average remaining lease term was 10.8 years and 11.7 years as of December 31, 2024 and 2023, respectively. The weighted average discount rate was 4.53% and 4.22% as of December 31, 2024 and 2023, respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Commitments and contingencies Purchase commitments Our purchase commitments include payments for software licenses and contractual arrangements with suppliers when there is a fixed, noncancelable payment schedule or when minimum payments are due with a reduced delivery schedule. As of December 31, 2024, we had committed to make the following minimum payments under our purchase commitments: 2025 2026 2027 2028 2029 Thereafter Total Purchase commitments $ 463 $ 317 $ 263 $ 135 $ 135 $ 104 $ 1,417 Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. Warranty costs/product liabilities Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our consolidated financial statements. We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. General We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our consolidated financial statements.

Supplemental financial informat

Supplemental financial information	12 Months Ended
	Dec. 31, 2024
Disclosure Text Block Supplement [Abstract]
Supplemental financial information	Supplemental financial information Restructuring charges/other During 2024, restructuring charges/other was a credit of $124 million primarily due to a gain on the sale of a property. During 2023, there were no restructuring charges/other. During 2022, restructuring charges/other was a cost of $257 million related to preproduction costs at our Lehi, Utah, manufacturing facility. These amounts are included in Other for segment reporting purposes. Other income (expense), net (OI&E) For Years Ended December 31, 2024 2023 2022 Other income (a) $ 534 $ 483 $ 169 Other expense (b) (38) (43) (63) Total $ 496 $ 440 $ 106 (a) Includes interest, royalty and lease income. (b) Includes a portion of pension and other retiree benefit costs, lease expense, tax interest, currency gains and losses and miscellaneous items. Prepaid expenses and other current assets December 31, 2024 2023 CHIPS Act incentives $ 904 $ 497 Other 296 264 Total $ 1,200 $ 761 Property, plant and equipment at cost Depreciable Lives (Years) December 31, 2024 2023 Land $ 113 $ 150 Buildings and improvements Up to 40 6,424 5,549 Machinery and equipment 5 – 10 8,717 7,569 Total $ 15,254 $ 13,268 Goodwill Goodwill by segment as of December 31, 2024 and 2023, is as follows: Goodwill Analog $ 4,158 Embedded Processing 172 Other 32 Total $ 4,362 We perform our annual goodwill impairment test in the fourth quarter and determine whether the fair value of each of our reporting units is in excess of its carrying value. In 2024, 2023 and 2022, we determined no impairment was indicated. Other long-term assets December 31, 2024 2023 CHIPS Act incentives $ 2,246 $ 859 Other 1,102 853 Total $ 3,348 $ 1,712 Accrued expenses and other liabilities December 31, 2024 2023 Accrued capital-related expenditures $ 352 $ 341 Other 723 570 Total $ 1,075 $ 911 Accumulated other comprehensive income (loss), net of taxes (AOCI) December 31, 2024 2023 Postretirement benefit plans: Net actuarial loss $ (144) $ (207) Prior service credit 1 — Unrealized gains on available-for-sale investments 2 2 Cash flow hedge derivative instruments 1 — Total $ (140) $ (205) Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income in 2024, 2023 and 2022. The table below details where these transactions are recorded in our Consolidated Statements of Income. For Years Ended December 31, Impact to Related Statement of Income Lines 2024 2023 2022 Net actuarial losses of defined benefit plans: Recognized net actuarial loss and settlement losses (a) $ 13 $ 20 $ 78 Decrease to OI&E Tax effect (3) (5) (17) Decrease to provision for income taxes Recognized within net income, net of taxes $ 10 $ 15 $ 61 Decrease to net income Prior service cost (credit) of defined benefit plans: Amortization of prior service cost (credit) (a) $ 1 $ 1 $ (1) Decrease (increase) to OI&E Tax effect — — — (Decrease) increase to provision for income taxes Recognized within net income, net of taxes $ 1 $ 1 $ (1) Decrease (increase) to net income (a) Detailed in Note 7

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net income	$ 4,799	$ 6,510	$ 8,749

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Cybersecurity risk management and strategy Our cybersecurity risk management is based on recognized cybersecurity industry frameworks and standards, including those of the National Institute of Standards and Technology, the Center for Internet Security Controls, and the International Organization for Standardization. We use these frameworks, together with information collected from internal assessments, to develop policies for use of our information assets (for example, TI business information and information resources such as mobile phones, computers and workstations), access to specific intellectual property or technologies, and protection of personal information. We protect these information assets through industry-standard techniques, such as multifactor authentication and malware defenses. We also work with internal stakeholders across the company to integrate foundational cybersecurity principles throughout our organization’s operations, including employment of multiple layers of cybersecurity defenses, restricted access based on business need, and integrity of our business information. Throughout the year, we also regularly train our employees on cybersecurity awareness, confidential information protection and simulated phishing attacks. We regularly engage third-party assessors to conduct penetration testing and measure our program to industry standard frameworks. We also have standing engagements with incident response experts and external counsel. We frequently collaborate with industry experts and cybersecurity practitioners at other companies to exchange information about potential cybersecurity threats, best practices and trends. Our cybersecurity risk management extends to risks associated with our use of third-party service providers. For instance, we conduct risk and compliance assessments of third-party service providers that request access to our information assets. Our cybersecurity risk management is an important part of our comprehensive business continuity program and enterprise risk management. Our global information security team periodically engages with a cross-functional group of subject matter experts and leaders to assess and refine our cybersecurity risk posture and preparedness. For example, we regularly evaluate and update contingency strategies for our business in the event that a portion of our information resources were to be unavailable due to a cybersecurity incident. We practice our response to potential cybersecurity incidents through regular tabletop exercises, threat hunting and red team exercises. For more information about cybersecurity risks, see the Risk factors discussion in Item 1A of this Form 10-K.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	Our cybersecurity risk management is based on recognized cybersecurity industry frameworks and standards, including those of the National Institute of Standards and Technology, the Center for Internet Security Controls, and the International Organization for Standardization. We use these frameworks, together with information collected from internal assessments, to develop policies for use of our information assets (for example, TI business information and information resources such as mobile phones, computers and workstations), access to specific intellectual property or technologies, and protection of personal information. We protect these information assets through industry-standard techniques, such as multifactor authentication and malware defenses. We also work with internal stakeholders across the company to integrate foundational cybersecurity principles throughout our organization’s operations, including employment of multiple layers of cybersecurity defenses, restricted access based on business need, and integrity of our business information. Throughout the year, we also regularly train our employees on cybersecurity awareness, confidential information protection and simulated phishing attacks.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	The board of directors, as a whole, has oversight responsibility for our strategic and operational risks. The audit committee assists the board of directors with this responsibility by reviewing and discussing our risk assessment and risk management practices, including cybersecurity risks, with members of management. The audit committee, in turn, periodically reports on its review with the board of directors.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	The board of directors, as a whole, has oversight responsibility for our strategic and operational risks. The audit committee assists the board of directors with this responsibility by reviewing and discussing our risk assessment and risk management practices, including cybersecurity risks, with members of management. The audit committee, in turn, periodically reports on its review with the board of directors.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	The audit committee assists the board of directors with this responsibility by reviewing and discussing our risk assessment and risk management practices, including cybersecurity risks, with members of management. The audit committee, in turn, periodically reports on its review with the board of directors.
Cybersecurity Risk Role of Management [Text Block]	Management is responsible for day-to-day assessment and management of cybersecurity risks. Our chief information officer has primary oversight of material risks from cybersecurity threats. Our chief information officer is the senior vice president responsible for the Information Technology Solutions (ITS) organization and for information protection. Our chief information officer has more than 25 years of experience across various engineering, business and management roles, including serving as the vice president of the design and manufacturing ITS organization, leading the development and implementation of information technology strategies and roadmaps for manufacturing automation. Our chief information security officer reports to our chief information officer. Our chief information security officer has more than 15 years of experience working in information technology-related roles, a degree in Information Technology, and Global Information Assurance Certifications in Security Essentials (GSEC) as an Intrusion Analyst (GCIA) and as a Penetration Tester (GPEN). Our chief information officer and chief information security officer assess our cybersecurity readiness through internal assessment tools as well as third-party control tests, vulnerability assessments, audits and evaluation against industry standards. We have governance and compliance structures that are designed to elevate issues relating to cybersecurity to our chief information officer and chief information security officer, such as potential threats or vulnerabilities. We also employ various defensive and continuous monitoring techniques using recognized industry frameworks and cybersecurity standards.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	The board of directors, as a whole, has oversight responsibility for our strategic and operational risks. The audit committee assists the board of directors with this responsibility by reviewing and discussing our risk assessment and risk management practices, including cybersecurity risks, with members of management. The audit committee, in turn, periodically reports on its review with the board of directors. Management is responsible for day-to-day assessment and management of cybersecurity risks. Our chief information officer has primary oversight of material risks from cybersecurity threats. Our chief information officer is the senior vice president responsible for the Information Technology Solutions (ITS) organization and for information protection. Our chief information officer has more than 25 years of experience across various engineering, business and management roles, including serving as the vice president of the design and manufacturing ITS organization, leading the development and implementation of information technology strategies and roadmaps for manufacturing automation. Our chief information security officer reports to our chief information officer. Our chief information security officer has more than 15 years of experience working in information technology-related roles, a degree in Information Technology, and Global Information Assurance Certifications in Security Essentials (GSEC) as an Intrusion Analyst (GCIA) and as a Penetration Tester (GPEN). Our chief information officer and chief information security officer assess our cybersecurity readiness through internal assessment tools as well as third-party control tests, vulnerability assessments, audits and evaluation against industry standards. We have governance and compliance structures that are designed to elevate issues relating to cybersecurity to our chief information officer and chief information security officer, such as potential threats or vulnerabilities. We also employ various defensive and continuous monitoring techniques using recognized industry frameworks and cybersecurity standards. Our chief information officer meets with the audit committee periodically to review our information technology systems and discuss key cybersecurity risks. In addition, the chief financial officer reviews with the audit committee at least annually our global enterprise risk management program, which includes cybersecurity risks, and is also reported to the board.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Our chief information security officer has more than 15 years of experience working in information technology-related roles, a degree in Information Technology, and Global Information Assurance Certifications in Security Essentials (GSEC) as an Intrusion Analyst (GCIA) and as a Penetration Tester (GPEN).
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Our chief information officer meets with the audit committee periodically to review our information technology systems and discuss key cybersecurity risks. In addition, the chief financial officer reviews with the audit committee at least annually our global enterprise risk management program, which includes cybersecurity risks, and is also reported to the board.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Basis of Presentation and Sig_2

Basis of Presentation and Significant Accounting Policies and Practices (Policies)	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP). The basis of these financial statements is comparable for all periods presented herein. The consolidated financial statements include the accounts of all subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. All dollar and share amounts in the financial statements and tables in these notes, except per-share amounts, are presented in millions unless otherwise indicated. We have reclassified certain amounts in the prior periods’ financial statements to conform to the 2024 presentation. The preparation of financial statements requires the use of estimates from which final results may vary.
Revenue recognition	Revenue recognition We generate revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, and recognize revenue when control is transferred. Control is considered transferred when title and risk of loss pass, when the customer becomes obligated to pay and, where required, when the customer has accepted the products. This transfer generally occurs at a point in time upon shipment or delivery to the customer or distributor, depending upon the terms of the sales order. Payment for sales to customers and distributors is generally due on our standard commercial terms. For sales to distributors, payment is not contingent upon resale of the products. Revenue from sales of our products that are subject to inventory consignment agreements is recognized at a point in time, when the customer or distributor pulls product from consignment inventory that we store at designated locations. Delivery and transfer of control occur at that point, when title and risk of loss transfers and the customer or distributor becomes obligated to pay for the products pulled from inventory. Until the products are pulled for use or sale by the customer or distributor, we retain control over the products’ disposition, including the right to pull back or relocate the products. The revenue recognized is adjusted based on allowances, which are prepared on a portfolio basis using a most likely amount methodology based on analysis of historical data and contractual terms. These allowances, which are not material, generally include adjustments for pricing arrangements, product returns and incentives. We recognize shipping fees received from customers, if any, in revenue. We include the related shipping and handling costs in cost of revenue. The majority of our customers pay these fees directly to third parties.
Advertising costs	Advertising costs
Income taxes	Income taxes We account for income taxes using an asset and liability approach. We record the amount of taxes payable or refundable for the current year and the deferred tax assets and liabilities for future tax consequences related to events that have been recognized in the financial statements or tax returns. We record a valuation allowance when it is more likely than not that some or all of the deferred tax assets will not be realized.
Other assessed taxes	Other assessed taxes Some transactions require us to collect taxes such as sales, value-added and excise taxes from our customers. These transactions are presented in our Consolidated Statements of Income on a net (excluded from revenue) basis.
Leases	Leases We determine if an arrangement is a lease at inception. Leases are included in other long-term assets, accrued expenses and other liabilities, and other long-term liabilities on our Consolidated Balance Sheets. Lease assets represent our right to use underlying assets for the lease term, and lease liabilities represent our obligations to make lease payments over the lease term. On the commencement date, leases are evaluated for classification, and assets and liabilities are recognized based on the present value of lease payments over the lease term. We use our incremental borrowing rate based on the information available at commencement in determining the present value of lease payments. Operating lease expense is generally recognized on a straight-line basis over the lease term. Our lease values include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. We have agreements with lease and non-lease components, which are accounted for as a single lease component. Leases with an initial lease term of 12 months or less are not recorded on the balance sheet.
Earnings per share (EPS)	Earnings per share (EPS) We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing nonforfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded from the calculation of income allocated to common stock.
Investments	Investments We present investments on our Consolidated Balance Sheets as cash equivalents, short-term investments or other long-term assets. See Note 6 for additional information. • Cash equivalents and short-term investments – The primary objectives of our cash equivalent and short-term investment activities are to preserve capital and maintain liquidity while generating appropriate returns. We consider investments in available-for-sale debt securities with maturities of 90 days or less from the date of our investment to be cash equivalents. We consider investments in available-for-sale debt securities with maturities beyond 90 days from the date of our investment as being available for use in current operations and include them in short-term investments. • Other long-term assets – Long-term investments, which are included within other long-term assets on our Consolidated Balance Sheets, consist of mutual funds, venture capital funds and nonmarketable securities. Investments measured at fair value Money market funds, debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes. We classify all debt investments as available-for-sale. See Fair-value considerations. Unrealized gains and losses are recorded as an increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses are recorded as an allowance for credit losses with an offset recognized in OI&E in our Consolidated Statements of Income. Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A. Other investments Our other investments include equity-method investments and nonmarketable investments, which are not measured at fair value. These investments consist of interests in venture capital funds and other nonmarketable securities. Gains and losses from equity-method investments are recognized in OI&E based on our ownership share of the investee’s financial results. Nonmarketable securities are measured at cost with adjustments for observable changes in price or impairments. Gains and losses on nonmarketable investments are recognized in OI&E.
Inventories	Inventories Inventories are stated at the lower of cost or estimated net realizable value. Cost is generally computed on a currently adjusted standard cost basis, which approximates cost on a first-in, first-out basis. Standard cost is based on the normal utilization of installed factory capacity. Cost associated with underutilization of capacity is expensed as incurred. Inventory held at consignment locations is included in our finished goods inventory. We review inventory quarterly for salability and obsolescence. A statistical allowance is provided for inventory considered unlikely to be sold. The statistical allowance is based on an analysis of historical disposal activity, historical customer shipments and age of inventory. A specific allowance for each material type will be carried if there is a significant event not captured by the statistical allowance. We write off inventory in the period in which disposal occurs.
Government incentives	Government incentives Incentives provided by government entities are recognized when we have reasonable assurance that we will comply with the conditions of the incentive, if any, and the incentive will be received. Incentives, which include non-income tax incentives, related to the acquisition or construction of fixed assets are recognized as a reduction in the carrying amounts of the related assets and reduce depreciation expense over the useful lives of the assets. Incentives for specific operating activities are offset against the related expense in the period the expense is incurred.
Property, plant and equipment and other capitalized costs	Property, plant and equipment and other capitalized costs Property, plant and equipment are stated at cost and depreciated over their estimated useful lives using the straight-line method. Our cost basis includes certain assets acquired in business combinations that were initially recorded at fair value as of the date of acquisition. Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements. We amortize acquisition-related intangibles on a straight-line basis over the estimated economic life of the assets. Capitalized software licenses are generally amortized on a straight-line basis over the term of the license. Fully depreciated or amortized assets are written off against accumulated depreciation or amortization.
Impairments of long-lived assets	Impairments of long-lived assets We regularly review whether facts or circumstances exist that indicate the carrying values of property, plant and equipment or other long-lived assets, including intangible assets, are impaired. We assess the recoverability of assets by comparing the projected undiscounted net cash flows associated with those assets to their respective carrying amounts. Any impairment charge is based on the excess of the carrying amount over the fair value of those assets. Fair value is determined by available market valuations, if applicable, or by discounted cash flows.
Goodwill	Goodwill Goodwill is reviewed for impairment annually in the fourth quarter or more frequently if certain impairment indicators arise. We perform a qualitative assessment to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. If we determine that it is more likely than not that the fair value of a reporting unit is less than its carrying value, or if we elect not to use a qualitative assessment, then we perform a quantitative goodwill impairment test. See Note 11 for additional information.
Foreign currency	Foreign currency The functional currency for our non-U.S. subsidiaries is the U.S. dollar. Accounts recorded in currencies other than the U.S. dollar are remeasured into the functional currency. Current assets (except inventories), deferred taxes, current liabilities and long-term liabilities are remeasured at exchange rates in effect at the end of each reporting period. Property, plant and equipment with associated depreciation and inventories are valued at historical exchange rates. Revenue and expense accounts other than depreciation for each month are calculated at the appropriate daily rate of exchange. Currency exchange gains and losses from remeasurement are credited or charged to OI&E.
Derivatives and hedging	Derivatives and hedging We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments. We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the value of the swaps and the related deferred compensation liabilities in SG&A. In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are recognized in AOCI and amortized over the life of the related debt. The results of these derivative transactions were not material. We do not use derivatives for speculative or trading purposes.
Stock compensation	We recognize compensation expense for non-qualified stock options and RSUs on a straight-line basis over the minimum service period required for vesting of the award, adjusting for estimated forfeitures based on historical activity. Awards issued to employees who are retirement eligible or nearing retirement eligibility are expensed on an accelerated basis. Options issued under our ESPP are expensed over a three-month period. We use market-based measures of implied volatility to determine expected volatility on all options granted. We determine expected lives of options based on the historical option exercise experience of our option holders using a rolling 10-year average. Expected dividend yields are based on the annualized approved quarterly dividend rate and the current market price of our common stock at the time of grant. No assumption for a future dividend rate change is included unless there is an approved plan to change the dividend in the near term.
Fair values considerations	Fair-value considerations We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The three-level hierarchy described below indicates the inputs used to estimate fair-value measurements. • Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the measurement date. • Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the measurement date through correlation with market data. Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active and models or other pricing methodologies that do not require significant judgment. We utilize a third-party data service to provide Level 2 valuations, and we verify these valuations for reasonableness. • Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management judgment. As of December 31, 2024 and 2023, we had no Level 3 assets or liabilities.
Indemnification guarantees and warranty costs/product liabilities	Indemnification guarantees We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result. Warranty costs/product liabilities Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our consolidated financial statements. We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability.

Description of Business, Incl_2

Description of Business, Including Segment and Geographic Area Information (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Revenue and Operating Profit, by Segment	Segment information For Year Ended December 31, 2024 Analog Embedded Processing Other Total Revenue $ 12,161 $ 2,533 $ 947 $ 15,641 Cost of revenue 4,869 1,315 363 6,547 Gross profit 7,292 1,218 584 9,094 Research and development 1,411 475 73 1,959 Selling, general and administrative 1,273 391 130 1,794 Restructuring charges/other — — (124) (124) Operating profit $ 4,608 $ 352 $ 505 $ 5,465 For Year Ended December 31, 2023 Analog Embedded Processing Other Total Revenue $ 13,040 $ 3,368 $ 1,111 $ 17,519 Cost of revenue 4,615 1,493 392 6,500 Gross profit 8,425 1,875 719 11,019 Research and development 1,317 457 89 1,863 Selling, general and administrative 1,287 410 128 1,825 Restructuring charges/other — — — — Operating profit $ 5,821 $ 1,008 $ 502 $ 7,331 For Year Ended December 31, 2022 Analog Embedded Processing Other Total Revenue $ 15,359 $ 3,261 $ 1,408 $ 20,028 Cost of revenue 4,610 1,223 424 6,257 Gross profit 10,749 2,038 984 13,771 Research and development 1,178 413 79 1,670 Selling, general and administrative 1,212 372 120 1,704 Restructuring charges/other — — 257 257 Operating profit $ 8,359 $ 1,253 $ 528 $ 10,140
Schedule of Revenue, by Geographic Area	Geographic area information Our estimate for revenue based on the geographic location of our end customers’ headquarters, which represents where critical decisions are made, is as follows: For Years Ended December 31, 2024 2023 2022 Revenue: United States $ 5,957 38 % $ 5,814 33 % $ 6,609 33 % China 3,012 19 3,293 19 4,807 24 Rest of Asia 1,681 11 1,721 10 2,003 10 Europe, Middle East and Africa (a) 3,519 22 4,642 26 4,807 24 Japan 1,212 8 1,782 10 1,602 8 Rest of world 260 2 267 2 200 1 Total revenue $ 15,641 100 % $ 17,519 100 % $ 20,028 100 % (a) Revenue from end customers headquartered in Germany was 11%, 13% and 11% of total revenue in 2024, 2023 and 2022, respectively.
Schedule Property, Plant and Equipment by Geographic Area	Property, plant and equipment by geographic area, based on physical location: December 31, 2024 2023 Property, plant and equipment: United States $ 8,342 $ 7,548 China 737 731 Rest of Asia 1,877 1,433 Europe, Middle East and Africa 74 68 Japan 274 169 Rest of world 43 50 Total property, plant and equipment $ 11,347 $ 9,999

Basis of Presentation and Sig_3

Basis of Presentation and Significant Accounting Policies and Practices (Tables)	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Earnings per Share, Basic and Diluted	Computation and reconciliation of earnings per common share are as follows: For Years Ended December 31, 2024 2023 2022 Net Income Shares EPS Net Income Shares EPS Net Income Shares EPS Basic EPS: Net income $ 4,799 $ 6,510 $ 8,749 Income allocated to RSUs (24) (34) (40) Income allocated to common stock $ 4,775 912 $ 5.24 $ 6,476 908 $ 7.13 $ 8,709 916 $ 9.51 Dilutive effect of stock compensation plans 7 8 10 Diluted EPS: Net income $ 4,799 $ 6,510 $ 8,749 Income allocated to RSUs (24) (33) (39) Income allocated to common stock $ 4,775 919 $ 5.20 $ 6,477 916 $ 7.07 $ 8,710 926 $ 9.41

Stock Compensation (Tables)

Stock Compensation (Tables)	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Compensation Expense Allocation Within the Consolidated Statements of Income	Total stock compensation expense recognized is as follows: For Years Ended December 31, 2024 2023 2022 COR $ 52 $ 44 $ 34 R&D 132 119 90 SG&A 203 199 165 Total $ 387 $ 362 $ 289
Schedule of Weighted Average Assumptions Used to Estimate the Fair Values for Non-qualified Stock Options	We estimate the fair values for non-qualified stock options using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions: For Years Ended December 31, 2024 2023 2022 Weighted average grant date fair value, per share $ 37.58 $ 46.23 $ 39.94 Weighted average assumptions used: Expected volatility 27 % 31 % 29 % Expected lives (in years) 5.6 6.1 6.4 Risk-free interest rates 4.04 % 3.60 % 1.83 % Expected dividend yields 3.11 % 2.86 % 2.64 %
Schedule of Stock Option and RSU Transactions Under Long-term Incentive and Director Compensation Plans	Stock option and RSU transactions under our long-term incentive and director compensation plans are as follows: Stock Options RSUs Shares Weighted Average Exercise Price per Share Shares Weighted Average Grant Date Fair Value per Share Outstanding grants, December 31, 2023 26 $ 119.60 5 $ 161.40 Granted 5 $ 167.68 2 $ 173.59 Stock options exercised/RSUs vested (6) $ 82.42 (1) $ 131.82 Outstanding grants, December 31, 2024 (a) 25 $ 136.87 6 $ 168.68 (a) Forfeited and expired shares were not material. For Years Ended December 31, 2024 2023 2022 Weighted average grant date fair value per share for RSUs $ 173.59 $ 172.59 $ 174.39 Total grant date fair value of shares vested for RSUs $ 113 $ 106 $ 121 Aggregate intrinsic value of options exercised $ 597 $ 319 $ 336
Schedule of Shares Outstanding Under Stock Option Plans, by Exercise Price Range	Summarized information about stock options outstanding as of December 31, 2024, is as follows: Exercise Price Range Number Outstanding (Shares) Weighted Average Remaining Contractual Life (Years) $49.03 to $206.61 25 5.7
Schedule of Stock Options That are Vested and Expected to Vest, Outstanding and Exercisable	Options Fully Vested and Expected to Vest (a) Options Exercisable Stock options outstanding (shares) 24 15 Weighted average remaining contractual life (in years) 5.7 4.0 Weighted average exercise price per share $ 136.44 $ 114.61 Intrinsic value (billions) $ 1.24 $ 1.08 (a) Includes effects of expected forfeitures. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $1.24 billion.
Schedule of Changes in Treasury Stock	The following table reflects the changes in our treasury shares: For Years Ended December 31, 2024 2023 2022 Balance, January 1 832 835 817 Repurchases 5 2 22 Shares issued (7) (5) (4) Balance, December 31 830 832 835
Schedule of Cash Proceeds Received from Share-based Payment Awards	The effects on cash flows are as follows: For Years Ended December 31, 2024 2023 2022 Proceeds from common stock transactions (a) $ 517 $ 263 $ 241 Tax benefit realized from stock compensation $ 158 $ 104 $ 110 (a) Net of taxes paid for employee shares withheld of $39 million, $46 million and $50 million in 2024, 2023 and 2022, respectively.

Income taxes (Tables)

Income taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income before income taxes	Income before income taxes is comprised of the following components: For Years Ended December 31, 2024 2023 2022 U.S. $ 4,438 $ 6,445 $ 9,122 Non-U.S. 1,015 973 910 Total $ 5,453 $ 7,418 $ 10,032
Provision for income taxes	Provision for income taxes is comprised of the following components: For Years Ended December 31, 2024 2023 2022 Current Deferred Total Current Deferred Total Current Deferred Total U.S. federal $ 605 $ (139) $ 466 $ 943 $ (277) $ 666 $ 1,235 $ (223) $ 1,012 Non-U.S. 244 (71) 173 240 (22) 218 212 32 244 U.S. state 15 — 15 24 — 24 27 — 27 Total $ 864 $ (210) $ 654 $ 1,207 $ (299) $ 908 $ 1,474 $ (191) $ 1,283
Principal reconciliation items from U.S. statutory income tax rate to the effective tax rate	Principal reconciling items from the U.S. statutory income tax rate to the effective tax rate (provision for income taxes as a percentage of income before income taxes) are as follows: For Years Ended December 31, 2024 2023 2022 U.S. statutory income tax rate 21.0 % 21.0 % 21.0 % Foreign derived intangible income (6.1) (6.8) (7.0) Stock compensation (2.1) (1.0) (0.7) R&D tax credit (2.0) (1.3) (0.9) Changes in uncertain tax positions 0.1 — 0.1 Other 1.1 0.3 0.3 Effective tax rate 12.0 % 12.2 % 12.8 %
Primary components of deferred tax assets and liabilities	The primary components of deferred tax assets and liabilities are as follows: December 31, 2024 2023 Deferred tax assets: Capitalized R&D $ 1,076 $ 750 Accrued expenses 297 236 Deferred loss and tax credit carryforwards 216 205 Stock compensation 186 163 Inventories 105 104 Retirement costs for defined benefit and retiree health care 17 37 Other 23 47 Total deferred tax assets, before valuation allowance 1,920 1,542 Valuation allowance (212) (198) Total deferred tax assets, after valuation allowance 1,708 1,344 Deferred tax liabilities: Property, plant and equipment (441) (592) CHIPS Act incentives (336) — International earnings (33) (33) Acquisition-related intangibles and fair-value adjustments (6) (14) Other (9) (11) Total deferred tax liabilities (825) (650) Net deferred tax asset $ 883 $ 694 The deferred tax assets and liabilities based on tax jurisdictions are presented on our Consolidated Balance Sheets as follows: December 31, 2024 2023 Deferred tax assets $ 936 $ 757 Deferred tax liabilities (53) (63) Net deferred tax asset $ 883 $ 694
Summary of uncertain tax positions	The changes in the total amounts of uncertain tax positions are as follows: 2024 2023 2022 Balance, January 1 $ 82 $ 82 $ 69 Additions based on tax positions related to the current year 3 3 3 Additions for tax positions of prior years — — 10 Reductions for tax positions of prior years — (3) — Balance, December 31 $ 85 $ 82 $ 82 Interest expense recognized in the year ended December 31 $ (5) $ (9) $ (1) Interest payable as of December 31 $ 15 $ 10 $ 3
Summary of uncertain tax positions	The changes in the total amounts of uncertain tax positions are as follows: 2024 2023 2022 Balance, January 1 $ 82 $ 82 $ 69 Additions based on tax positions related to the current year 3 3 3 Additions for tax positions of prior years — — 10 Reductions for tax positions of prior years — (3) — Balance, December 31 $ 85 $ 82 $ 82 Interest expense recognized in the year ended December 31 $ (5) $ (9) $ (1) Interest payable as of December 31 $ 15 $ 10 $ 3

Valuation of Debt and Equity _2

Valuation of Debt and Equity Investments and Certain Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Investments	Details of our investments are as follows: December 31, 2024 December 31, 2023 Cash and Cash Equivalents Short-Term Investments Long-Term Investments Cash and Cash Equivalents Short-Term Investments Long-Term Investments Measured at fair value: Money market funds $ 762 $ — $ — $ 1,068 $ — $ — Corporate obligations 694 796 — 349 1,605 — U.S. government and agency securities 752 3,485 — 696 3,808 — Non-U.S. government and agency securities 249 99 — 50 198 — Mutual funds — — 11 — — 12 Total 2,457 4,380 11 2,163 5,611 12 Other measurement basis: Equity-method investments — — 8 — — 17 Nonmarketable investments — — 4 — — 5 Total — — 12 — — 22 Cash on hand 743 — — 801 — — Total $ 3,200 $ 4,380 $ 23 $ 2,964 $ 5,611 $ 34
Aggregate Maturities of Available-for-sale Debt Investments	The following table presents the aggregate maturities of our debt investments as of December 31, 2024: Fair Value One year or less $ 5,348 One to two years 727
Assets and Liabilities Accounted for at Fair Value	The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value. December 31, 2024 December 31, 2023 Level 1 Level 2 Total Level 1 Level 2 Total Assets: Money market funds $ 762 $ — $ 762 $ 1,068 $ — $ 1,068 Corporate obligations — 1,490 1,490 — 1,954 1,954 U.S. government and agency securities 2,591 1,646 4,237 3,618 886 4,504 Non-U.S. government and agency securities — 348 348 — 248 248 Mutual funds 11 — 11 12 — 12 Total assets $ 3,364 $ 3,484 $ 6,848 $ 4,698 $ 3,088 $ 7,786 Liabilities: Deferred compensation $ 443 $ — $ 443 $ 393 $ — $ 393 Total liabilities $ 443 $ — $ 443 $ 393 $ — $ 393

Postretirement Benefit Plans (T

Postretirement Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Expense Related to Defined Benefit and Retiree Health Care Benefit Plans	Expenses related to defined benefit and retiree health care benefit plans are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit 2024 2023 2022 2024 2023 2022 2024 2023 2022 Service cost $ 7 $ 8 $ 15 $ 1 $ 2 $ 3 $ 16 $ 16 $ 25 Interest cost 25 28 29 13 15 11 55 57 33 Expected return on plan assets (23) (23) (27) (16) (19) (12) (77) (63) (66) Amortization of prior service cost (credit) — — — — — (2) 1 1 1 Recognized net actuarial losses (gains) 4 6 3 (3) (5) — 11 12 1 Net periodic benefit costs (credits) 13 19 20 (5) (7) — 6 23 (6) Settlement losses 1 7 64 — — — — — 10 Total, including other postretirement losses (gains) $ 14 $ 26 $ 84 $ (5) $ (7) $ — $ 6 $ 23 $ 4
Schedule of Changes in the Benefit Obligations and Plan Assets for the Defined Benefit and Retiree Health Care Benefit Plans	Changes in the benefit obligations and plan assets for defined benefit and retiree health care benefit plans are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit 2024 2023 2024 2023 2024 2023 Change in plan benefit obligation Benefit obligation at beginning of year: $ 505 $ 521 $ 258 $ 274 $ 1,732 $ 1,667 Service cost 7 8 1 2 16 16 Interest cost 25 28 13 15 55 57 Participant contributions — — 13 14 1 1 Benefits paid (36) (13) (39) (41) (83) (77) Settlements (2) (40) — — (6) (6) Actuarial loss (gain) (6) 1 (12) (6) (106) 80 Effects of exchange rate changes — — — — (87) (6) Benefit obligation at end of year $ 493 $ 505 $ 234 $ 258 $ 1,522 $ 1,732 Change in plan assets Fair value of plan assets at beginning of year: $ 418 $ 421 $ 264 $ 280 $ 1,866 $ 1,822 Actual return on plan assets 18 47 9 29 27 137 Employer contributions (qualified plans) — — 1 1 2 2 Employer contributions (non-qualified plans) 2 3 — — — — Participant contributions — — 13 14 1 1 Benefits paid (36) (13) (39) (41) (83) (77) Settlements (2) (40) — — (6) (6) Effects of exchange rate changes — — — — (99) (13) Other — — — (19) — — Fair value of plan assets at end of year $ 400 $ 418 $ 248 $ 264 $ 1,708 $ 1,866 Funded status at end of year $ (93) $ (87) $ 14 $ 6 $ 186 $ 134
Schedule of Amounts Recognized in our Balance Sheet	Amounts recognized on our Consolidated Balance Sheets as of December 31, are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit Total 2024 Overfunded retirement plans $ — $ 16 $ 217 $ 233 Accrued expenses and other liabilities & other long-term liabilities (10) — (6) (16) Underfunded retirement plans (83) (2) (25) (110) Funded status at end of 2024 $ (93) $ 14 $ 186 $ 107 2023 Overfunded retirement plans $ — $ 8 $ 165 $ 173 Accrued expenses and other liabilities & other long-term liabilities (5) — (7) (12) Underfunded retirement plans (82) (2) (24) (108) Funded status at end of 2023 $ (87) $ 6 $ 134 $ 53
Schedule of Change in AOCI	The change in AOCI is as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit Total Net Actuarial Loss Net Actuarial Gain Prior Service Cost Net Actuarial Loss Prior Service Credit Net Actuarial Loss Prior Service Credit AOCI balance, net of taxes, December 31, 2023 $ 62 $ (24) $ — $ 169 $ — $ 207 $ — Changes in AOCI by category: Adjustments (1) (5) — (67) — (73) — Recognized within net income (5) 3 — (11) (1) (13) (1) Tax effect 1 — — 22 — 23 — Total change to AOCI (5) (2) — (56) (1) (63) (1) AOCI balance, net of taxes, December 31, 2024 $ 57 $ (26) $ — $ 113 $ (1) $ 144 $ (1)
Schedule of Allocation of Plan Assets	The tables below set forth the fair value of our plan assets using the same three-level hierarchy of fair-value inputs described in Note 6. December 31, 2024 Level 1 Level 2 Other (a) Total Assets of U.S. defined benefit plan: Fixed income securities and cash equivalents $ 92 $ 51 $ 101 $ 244 Equity securities — — 156 156 Total $ 92 $ 51 $ 257 $ 400 Assets of U.S. retiree health care plan: Fixed income securities and cash equivalents $ 2 $ — $ 196 $ 198 Equity securities — — 50 50 Total $ 2 $ — $ 246 $ 248 Assets of non-U.S. defined benefit plans: Fixed income securities and cash equivalents $ 15 $ 475 $ 820 $ 1,310 Equity securities 27 1 370 398 Total $ 42 $ 476 $ 1,190 $ 1,708 (a) Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents. December 31, 2023 Level 1 Level 2 Other (a) Total Assets of U.S. defined benefit plan: Fixed income securities and cash equivalents $ — $ — $ 272 $ 272 Equity securities — — 146 146 Total $ — $ — $ 418 $ 418 Assets of U.S. retiree health care plan: Fixed income securities and cash equivalents $ 4 $ — $ 206 $ 210 Equity securities — — 54 54 Total $ 4 $ — $ 260 $ 264 Assets of non-U.S. defined benefit plans: Fixed income securities and cash equivalents $ 49 $ 52 $ 1,343 $ 1,444 Equity securities 57 1 364 422 Total $ 106 $ 53 $ 1,707 $ 1,866 (a) Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents. The target allocation ranges for the plans that hold a substantial majority of the defined benefit assets are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit Fixed income securities and cash equivalents 60% – 75% 75% – 85% 60% – 100% Equity securities 25% – 40% 15% – 25% 0% – 40% Weighted average asset allocations as of December 31 are as follows: U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit 2024 2023 2024 2023 2024 2023 Fixed income securities and cash equivalents 61% 65% 80% 80% 77% 77% Equity securities 39% 35% 20% 20% 23% 23%
Schedule of Assumptions Used	Assumptions and investment policies U.S. Defined Benefit U.S. Retiree Health Care Non-U.S. Defined Benefit 2024 2023 2024 2023 2024 2023 Weighted average assumptions used to determine benefit obligations: Discount rate 5.55% 5.20% 5.65% 5.17% 3.76% 3.28% Long-term pay progression 3.00% 3.00% n/a n/a 3.14% 3.12% Weighted average assumptions used to determine net periodic benefit cost: Discount rate 5.21% 5.67% 5.17% 5.68% 3.28% 3.45% Long-term rate of return on plan assets 6.10% 5.70% 6.00% 5.70% 4.28% 3.50% Long-term pay progression 3.00% 3.75% n/a n/a 3.12% 3.03%
Schedule of Assumed Future Benefit Payments	The following assumed future benefit payments to plan participants in the next 10 years are used to measure our benefit obligations. Almost all of the payments, which may vary significantly from these assumptions, will be made from plan assets and not from company assets. 2025 2026 2027 2028 2029 2030 – 2034 U.S. Defined Benefit $ 80 $ 76 $ 67 $ 60 $ 54 $ 193 U.S. Retiree Health Care 25 24 23 21 21 92 Non-U.S. Defined Benefit 85 88 88 90 92 476
Schedule of Assumed Health Care Cost Trend Rates for U.S Retiree Health Care Benefit Plan	Assumed health care cost trend rates for the U.S. retiree health care benefit plan as of December 31 are as follows: 2024 2023 Assumed health care cost trend rate for next year 7.00% 7.00% Ultimate trend rate 5.00% 5.00% Year in which ultimate trend rate is reached 2033 2032

Debt and Lines of Credit (Table

Debt and Lines of Credit (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	Long-term debt outstanding is as follows: December 31, 2024 2023 Notes due 2024 at 2.625% $ — $ 300 Notes due 2024 at 4.70% — 300 Notes due 2025 at 1.375% 750 750 Notes due 2026 at 1.125% 500 500 Notes due 2027 at 4.60% 650 — Notes due 2027 at 2.90% 500 500 Notes due 2028 at 4.60% 700 700 Notes due 2029 at 4.60% 650 — Notes due 2029 at 2.25% 750 750 Notes due 2030 at 1.75% 750 750 Notes due 2031 at 1.90% 500 500 Notes due 2032 at 3.65% 400 400 Notes due 2033 at 4.90% 950 950 Notes due 2034 at 4.85% 600 — Notes due 2039 at 3.875% 750 750 Notes due 2048 at 4.15% 1,500 1,500 Notes due 2051 at 2.70% 500 500 Notes due 2052 at 4.10% 300 300 Notes due 2053 at 5.00% 650 650 Notes due 2054 at 5.15% 750 — Notes due 2063 at 5.05% 1,550 1,200 Total debt 13,700 11,300 Net unamortized discounts, premiums and issuance costs (104) (77) Total debt, including net unamortized discounts, premiums and issuance costs 13,596 11,223 Current portion of long-term debt (750) (599) Long-term debt $ 12,846 $ 10,624

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Balance sheet components of leases	Our leases are included as a component of the following balance sheet lines: December 31, 2024 2023 Other long-term assets $ 786 $ 579 Accrued expenses and other liabilities $ 118 $ 88 Other long-term liabilities 663 478
Schedule of Operating Leases	Details of our operating leases are as follows: For Years Ended 2024 2023 2022 Lease cost related to lease liabilities $ 85 $ 73 $ 67 Variable lease cost 64 54 46 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for lease cost $ 65 $ 65 $ 61 Lease assets obtained in exchange for new lease liabilities $ 241 $ 285 $ 37
Maturities of operating leases	As of December 31, 2024, we had committed to make the following minimum payments under our noncancelable operating leases: 2025 2026 2027 2028 2029 Thereafter Total Lease payments $ 121 $ 114 $ 103 $ 92 $ 80 $ 489 $ 999 Imputed lease interest (218) Total lease liabilities $ 781

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Minimum Payments Under Purchase Commitments	As of December 31, 2024, we had committed to make the following minimum payments under our purchase commitments: 2025 2026 2027 2028 2029 Thereafter Total Purchase commitments $ 463 $ 317 $ 263 $ 135 $ 135 $ 104 $ 1,417

Supplemental financial inform_2

Supplemental financial information (Tables)	12 Months Ended
	Dec. 31, 2024
Disclosure Text Block Supplement [Abstract]
Other income (expense), net (OI&E)	Other income (expense), net (OI&E) For Years Ended December 31, 2024 2023 2022 Other income (a) $ 534 $ 483 $ 169 Other expense (b) (38) (43) (63) Total $ 496 $ 440 $ 106 (a) Includes interest, royalty and lease income. (b) Includes a portion of pension and other retiree benefit costs, lease expense, tax interest, currency gains and losses and miscellaneous items.
Prepaid expenses and other current assets	Prepaid expenses and other current assets December 31, 2024 2023 CHIPS Act incentives $ 904 $ 497 Other 296 264 Total $ 1,200 $ 761
Property, plant and equipment at cost	Property, plant and equipment at cost Depreciable Lives (Years) December 31, 2024 2023 Land $ 113 $ 150 Buildings and improvements Up to 40 6,424 5,549 Machinery and equipment 5 – 10 8,717 7,569 Total $ 15,254 $ 13,268
Schedule of goodwill	Goodwill by segment as of December 31, 2024 and 2023, is as follows: Goodwill Analog $ 4,158 Embedded Processing 172 Other 32 Total $ 4,362
Other long-term assets	Other long-term assets December 31, 2024 2023 CHIPS Act incentives $ 2,246 $ 859 Other 1,102 853 Total $ 3,348 $ 1,712
Accrued expenses and other liabilities	Accrued expenses and other liabilities December 31, 2024 2023 Accrued capital-related expenditures $ 352 $ 341 Other 723 570 Total $ 1,075 $ 911
Accumulated other comprehensive income (loss), net of taxes (AOCI)	Accumulated other comprehensive income (loss), net of taxes (AOCI) December 31, 2024 2023 Postretirement benefit plans: Net actuarial loss $ (144) $ (207) Prior service credit 1 — Unrealized gains on available-for-sale investments 2 2 Cash flow hedge derivative instruments 1 — Total $ (140) $ (205)
Amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income	The table below details where these transactions are recorded in our Consolidated Statements of Income. For Years Ended December 31, Impact to Related Statement of Income Lines 2024 2023 2022 Net actuarial losses of defined benefit plans: Recognized net actuarial loss and settlement losses (a) $ 13 $ 20 $ 78 Decrease to OI&E Tax effect (3) (5) (17) Decrease to provision for income taxes Recognized within net income, net of taxes $ 10 $ 15 $ 61 Decrease to net income Prior service cost (credit) of defined benefit plans: Amortization of prior service cost (credit) (a) $ 1 $ 1 $ (1) Decrease (increase) to OI&E Tax effect — — — (Decrease) increase to provision for income taxes Recognized within net income, net of taxes $ 1 $ 1 $ (1) Decrease (increase) to net income (a) Detailed in Note 7

Description of Business, Incl_3

Description of Business, Including Segment and Geographic Area Information - Additional Information (Details)	12 Months Ended
	Dec. 31, 2024 reportable_segment productLine
Segment Reporting [Abstract]
Number of reportable segments | reportable_segment	2
Number of product lines, analog segment | productLine	2

Description of Business, Incl_4

Description of Business, Including Segment and Geographic Area Information - Schedule of Revenue and Operating Profit by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total revenue	$ 15,641	$ 17,519	$ 20,028
Cost of revenue (COR)	6,547	6,500	6,257
Gross profit	9,094	11,019	13,771
Research and development (R&D)	1,959	1,863	1,670
Selling, general and administrative (SG&A)	1,794	1,825	1,704
Restructuring charges/other	(124)	0	257
Operating profit	5,465	7,331	10,140
Analog
Segment Reporting Information [Line Items]
Total revenue	12,161	13,040	15,359
Cost of revenue (COR)	4,869	4,615	4,610
Gross profit	7,292	8,425	10,749
Research and development (R&D)	1,411	1,317	1,178
Selling, general and administrative (SG&A)	1,273	1,287	1,212
Restructuring charges/other	0	0	0
Operating profit	4,608	5,821	8,359
Embedded Processing
Segment Reporting Information [Line Items]
Total revenue	2,533	3,368	3,261
Cost of revenue (COR)	1,315	1,493	1,223
Gross profit	1,218	1,875	2,038
Research and development (R&D)	475	457	413
Selling, general and administrative (SG&A)	391	410	372
Restructuring charges/other	0	0	0
Operating profit	352	1,008	1,253
Other
Segment Reporting Information [Line Items]
Total revenue	947	1,111	1,408
Cost of revenue (COR)	363	392	424
Gross profit	584	719	984
Research and development (R&D)	73	89	79
Selling, general and administrative (SG&A)	130	128	120
Restructuring charges/other	(124)	0	257
Operating profit	$ 505	$ 502	$ 528

Description of Business, Incl_5

Description of Business, Including Segment and Geographic Area Information - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total revenue		$ 15,641	$ 17,519	$ 20,028
Revenue from Contract with Customer, Product and Service Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Total revenue		$ 15,641	$ 17,519	$ 20,028
Concentration risk		100%	100%	100%
United States | Revenue from Contract with Customer, Product and Service Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Total revenue		$ 5,957	$ 5,814	$ 6,609
Concentration risk		38%	33%	33%
China | Revenue from Contract with Customer, Product and Service Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Total revenue		$ 3,012	$ 3,293	$ 4,807
Concentration risk		19%	19%	24%
Rest of Asia | Revenue from Contract with Customer, Product and Service Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Total revenue		$ 1,681	$ 1,721	$ 2,003
Concentration risk		11%	10%	10%
Europe, Middle East and Africa | Revenue from Contract with Customer, Product and Service Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Total revenue	[1]	$ 3,519	$ 4,642	$ 4,807
Concentration risk	[1]	22%	26%	24%
Japan | Revenue from Contract with Customer, Product and Service Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Total revenue		$ 1,212	$ 1,782	$ 1,602
Concentration risk		8%	10%	8%
Rest of world | Revenue from Contract with Customer, Product and Service Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Total revenue		$ 260	$ 267	$ 200
Concentration risk		2%	2%	1%
Germany | Revenue from Contract with Customer, Product and Service Benchmark | Geographic Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk		11%	13%	11%
[1] Revenue from end customers headquartered in Germany was 11%, 13% and 11% of total revenue in 2024, 2023 and 2022, respectively.

Description of Business, Incl_6

Description of Business, Including Segment and Geographic Area Information - Schedule of Property, Plant and Equipment by Geographic Area (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Total property, plant and equipment	$ 11,347	$ 9,999
Customer Number One | Revenue Benchmark | Customer Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk	12%
United States
Segment Reporting Information [Line Items]
Total property, plant and equipment	$ 8,342	7,548
China
Segment Reporting Information [Line Items]
Total property, plant and equipment	737	731
Rest of Asia
Segment Reporting Information [Line Items]
Total property, plant and equipment	1,877	1,433
Europe, Middle East and Africa
Segment Reporting Information [Line Items]
Total property, plant and equipment	74	68
Japan
Segment Reporting Information [Line Items]
Total property, plant and equipment	274	169
Rest of world
Segment Reporting Information [Line Items]
Total property, plant and equipment	$ 43	$ 50

Basis of Presentation and Sig_4

Basis of Presentation and Significant Accounting Policies and Practices - Additional Information (Details) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) investment shares	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($) shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Advertising expense	$ 30	$ 28	$ 27
Antidilutive securities excluded from computation of earnings per share, Amount (in shares) | shares	8	10	5
Maximum length to maturity of a security, where it is classified as cash and cash equivalent	90 days
Length to maturity from the investment date of a security, short-term investment	90 days
CHIPS Act investment for Direct Funding	$ 1,600
Number of large scale 300mm water fabs | investment	3
Government incentives total	$ 3,150
Government incentive, current	904	$ 497
Government incentive, noncurrent	$ 2,246	859
Government Assistance, Statement of Financial Position [Extensible Enumeration]	Other long-term assets
Deferred income	$ 600
Government Assistance, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long-term liabilities
Total cash benefit related to the U.S CHIPS and Science Act	$ 588	0	$ 0
Decrease in manufacturing assets carrying value	$ 3,140
Government Assistance, Asset, Decrease, Statement of Financial Position [Extensible Enumeration]	Property, Plant and Equipment, Net
Amount of incentives recognized during the period	$ 1,780
CHIPS Act incentives benefit amount	$ 159	$ 45
Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of revenue (COR)

Basis of Presentation and Sig_5

Basis of Presentation and Significant Accounting Policies and Practices - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Basic EPS:
Net income	$ 4,799	$ 6,510	$ 8,749
Income allocated to RSUs	(24)	(34)	(40)
Income allocated to common stock for basic EPS	$ 4,775	$ 6,476	$ 8,709
Weighted average number of shares outstanding, basic (in shares)	912	908	916
Basic earnings per common share (in dollars per share)	$ 5.24	$ 7.13	$ 9.51
Dilutive effect of stock compensation plans	7	8	10
Diluted EPS:
Net income	$ 4,799	$ 6,510	$ 8,749
Income allocated to RSUs	(24)	(33)	(39)
Income allocated to common stock for diluted EPS	$ 4,775	$ 6,477	$ 8,710
Weighted average number of shares outstanding, diluted (in shares)	919	916	926
Diluted earnings per common share (in dollars per share)	$ 5.20	$ 7.07	$ 9.41

Stock Compensation - Additional

Stock Compensation - Additional Information (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) shares
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share of TI common stock (in shares)	1
Number of shares remaining available for future issuance (in shares)	35,000,000
Future compensation not yet recognized in the Statements of Income | $	$ 503
Weighted average recognition period	1 year 8 months 12 days
Expected life of options	10 years
Remaining stock repurchase authorizations | $	$ 20,260
Employee stock purchase plan
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Percent of the underlying common stock's market price participants pay for options (in hundredths)	85%
Number of shares remaining available for future issuance (in shares)	31,000,000
ESPP option term (in months)	3 months
Long-term incentive and director compensation plans | Employee Stock Option
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Term of the long term incentive stock options	10 years
Award vesting period (in years)	4 years
Long-term incentive and director compensation plans | Restricted Stock Units (RSUs)
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Award vesting period (in years)	4 years

Stock Compensation - Expense (D

Stock Compensation - Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation	$ 387	$ 362	$ 289
COR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation	52	44	34
R&D
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation	132	119	90
SG&A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock compensation	$ 203	$ 199	$ 165

Stock Compensation - Fair-value

Stock Compensation - Fair-value Methods and Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Weighted average grant date fair value, per share (in dollars per share)	$ 37.58	$ 46.23	$ 39.94
Expected volatility (in percent)	27%	31%	29%
Expected lives	5 years 7 months 6 days	6 years 1 month 6 days	6 years 4 months 24 days
Risk-free interest rates (in percent)	4.04%	3.60%	1.83%
Expected dividend yields (in percent)	3.11%	2.86%	2.64%

Stock Compensation - Stock Opti

Stock Compensation - Stock Options and RSUs Outstanding (Details) - Long-term incentive and director compensation plans - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Employee Stock Option
Stock Options, Shares
Options outstanding, Beginning balance (in shares)	26
Granted (in shares)	5
Exercised (in shares)	(6)
Options outstanding, Ending balance (in shares)	25	26
Stock Options, Weighted Average Exercise Price per Share
Weighted-average exercise price, Outstanding, Beginning of period (in dollars per share)	$ 119.60
Weighted-average exercise price, Granted (in dollars per share)	167.68
Weighted-average exercise price, Exercised (in dollars per share)	82.42
Weighted-average exercise price, Outstanding, End of period (in dollars per share)	$ 136.87	$ 119.60
Restricted Stock Units, Weighted Average Grant Date Fair Value per Share
Aggregate intrinsic values of options exercised	$ 597	$ 319	$ 336
Restricted Stock Units (RSUs)
Restricted Stock Units, Shares
Awards outstanding other than options, Beginning balance (in shares)	5
Granted (in shares)	2
Vested (in shares)	(1)
Awards outstanding other than options, Ending balance (in shares)	6	5
Restricted Stock Units, Weighted Average Grant Date Fair Value per Share
Weighted-average grant date fair value, Beginning of period (in dollars per share)	$ 161.40
Weighted-average grant-date fair value, Granted (in dollars per share)	173.59	$ 172.59	$ 174.39
Weighted-average grant date fair value, Vested (in dollars per share)	131.82
Weighted-average grant date fair value, Ending of period (in dollars per share)	168.68	161.40
Weighted-average grant-date fair value, Granted (in dollars per share)	$ 173.59	$ 172.59	$ 174.39
Total fair values of shares vested from RSU lapses	$ 113	$ 106	$ 121

Stock Compensation - Exercise P

Stock Compensation - Exercise Price Range (Details) - Employee Stock Option - Long-term incentive and director compensation plans - $ / shares shares in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Minimum (in dollars per share)	$ 49.03
Exercise Price Range, Maximum (in dollars per share)	$ 206.61
Number Outstanding (Shares)	25	26
Weighted Average Remaining Contractual Life (Years)	5 years 8 months 12 days
Options Outstanding Weighted Average Exercise Price per Share (in dollars per share)	$ 136.87	$ 119.60

Stock Compensation - Options Ve

Stock Compensation - Options Vested and Expected to Vest (Details) - Long-term incentive and director compensation plans - Employee Stock Option $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, vested and expected to vest (in shares) | shares	24	[1]
Weighted average remaining contractual life, vested and expected to vest (in years)	5 years 8 months 12 days	[1]
Weighted average exercise price per share, vested and expected to vest (in dollars per share) | $ / shares	$ 136.44	[1]
Intrinsic value, vested and expected to vest (millions of dollars)	$ 1,240	[1]
Outstanding options exercisable (in shares) | shares	15
Weighted average remaining contractual life, options exercisable	4 years
Weighted average exercise price per share, options exercisable (in dollars per share) | $ / shares	$ 114.61
Intrinsic value, options exercisable (millions of dollars)	$ 1,080
Aggregate intrinsic value of stock options outstanding, excluding the effects of expected forfeitures	$ 1,240
[1] Includes effects of expected forfeitures. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $1.24 billion.

Stock Compensation - Effect on

Stock Compensation - Effect on Shares Outstanding and Treasury Shares (Details) - shares shares in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Change In Treasury Stock Roll Forward [Roll Forward]
Treasury stock (in shares)	830	832	835	817
Repurchases (in shares)	5	2	22
Shares issued (in shares)	(7)	(5)	(4)

Stock Compensation - Effects on

Stock Compensation - Effects on Cash Flows (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Proceeds from common stock transactions	[1]	$ 517	$ 263	$ 241
Tax benefit realized from stock compensation		158	104	110
Taxes paid for employee shares withheld		$ 39	$ 46	$ 50
[1] Net of taxes paid for employee shares withheld of $39 million, $46 million and $50 million in 2024, 2023 and 2022, respectively.

Income taxes - Income before in

Income taxes - Income before income taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S.	$ 4,438	$ 6,445	$ 9,122
Non-U.S.	1,015	973	910
Income before income taxes	$ 5,453	$ 7,418	$ 10,032

Income taxes - Provision for in

Income taxes - Provision for income taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S. federal - Current	$ 605	$ 943	$ 1,235
Non-U.S. - Current	244	240	212
U.S. state - Current	15	24	27
Total current income tax expense (benefit)	864	1,207	1,474
U.S. federal - Deferred	(139)	(277)	(223)
Non-U.S. - Deferred	(71)	(22)	32
U.S. state - Deferred	0	0	0
Total deferred income tax expense (benefit)	(210)	(299)	(191)
Total U.S. federal income taxes	466	666	1,012
Total Non-U.S. income taxes	173	218	244
Total U.S. state income taxes	15	24	27
Provision for income taxes	$ 654	$ 908	$ 1,283

Income taxes - Reconciliation i

Income taxes - Reconciliation items from U.S. statutory income tax rate to the effective tax rate (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
U.S. statutory income tax rate	21%	21%	21%
Foreign derived intangible income	(6.10%)	(6.80%)	(7.00%)
R&D tax credit	(2.00%)	(1.30%)	(0.90%)
Stock compensation	(2.10%)	(1.00%)	(0.70%)
Changes in uncertain tax positions	0.10%	0%	0.10%
Other	1.10%	0.30%	0.30%
Effective tax rate	12%	12.20%	12.80%

Income taxes - Components of de

Income taxes - Components of deferred tax assets and liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Deferred tax assets:
Capitalized R&D	$ 1,076	$ 750
Accrued expenses	297	236
Deferred loss and tax credit carryforwards	216	205
Stock compensation	186	163
Inventories	105	104
Retirement costs for defined benefit and retiree health care	17	37
Other	23	47
Total deferred tax assets, before valuation allowance	1,920	1,542
Valuation allowance	(212)	(198)
Total deferred tax assets, after valuation allowance	1,708	1,344
Deferred tax liabilities:
Property, plant and equipment	(441)	(592)
CHIPS Act incentives	(336)	0
International earnings	(33)	(33)
Acquisition-related intangibles and fair-value adjustments	(6)	(14)
Other	(9)	(11)
Total deferred tax liabilities	(825)	(650)
Net deferred tax asset	$ 883	$ 694

Income taxes - Deferred tax ass

Income taxes - Deferred tax assets and liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Deferred tax assets	$ 936	$ 757
Deferred tax liabilities	(53)	(63)
Net deferred tax asset	$ 883	$ 694

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Change in deferred tax asset valuation allowances	$ 14,000,000	$ 9,000,000	$ 1,000,000
Net income impacted due to change in valuation allowances	0	0	0
Tax loss carryforward, U.S. and non-U.S.	0
Cash payments for income taxes	451,000,000	1,350,000,000	1,480,000,000
Liabilities for uncertain tax positions	$ 85,000,000	$ 82,000,000	$ 82,000,000	$ 69,000,000

Income taxes - Uncertain tax po

Income taxes - Uncertain tax positions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance, January 1	$ 82	$ 82	$ 69
Additions based on tax positions related to the current year	3	3	3
Additions for tax positions of prior years	0	0	10
Reductions for tax positions of prior years	0	(3)	0
Balance, December 31	85	82	82
Interest expense recognized in the year ended December 31	(5)	(9)	(1)
Interest payable as of December 31	$ 15	$ 10	$ 3

Financial Instruments and Ris_2

Financial Instruments and Risk Concentration (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Valuation and Qualifying Accounts Disclosure [Line Items]
Carrying value of long term debt	$ 13,596	$ 11,223
Allowance for Credit Loss
Valuation and Qualifying Accounts Disclosure [Line Items]
Accounts receivable allowances, amounts charged (credited) to operating results	5	$ 3	$ 5
Level 2
Valuation and Qualifying Accounts Disclosure [Line Items]
Fair value of long term debt	12,480
Foreign Exchange Forward
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional amount	565
Foreign Exchange Forward | Indian Rupees | Long
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional amount	180
Foreign Exchange Forward | British Pounds | Short
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional amount	91
Foreign Exchange Forward | Japanese Yen | Short
Valuation and Qualifying Accounts Disclosure [Line Items]
Notional amount	$ 78

Valuation of Debt and Equity _3

Valuation of Debt and Equity Investments and Certain Liabilities - Investments at Fair Value (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	$ 3,200	$ 2,964
Short-term investments	4,380	5,611
Long-Term Investments	23	34
Measured at fair value:
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	2,457	2,163
Short-term investments	4,380	5,611
Long-Term Investments	11	12
Measured at fair value: | Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	762	1,068
Short-term investments	0	0
Long-Term Investments	0	0
Measured at fair value: | Corporate obligations
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	694	349
Short-term investments	796	1,605
Long-Term Investments	0	0
Measured at fair value: | U.S. government and agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	752	696
Short-term investments	3,485	3,808
Long-Term Investments	0	0
Measured at fair value: | Non-U.S. government and agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	249	50
Short-term investments	99	198
Long-Term Investments	0	0
Measured at fair value: | Mutual funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-term investments	0	0
Long-Term Investments	11	12
Other measurement basis:
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-term investments	0	0
Long-Term Investments	12	22
Other measurement basis: | Equity-method investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-term investments	0	0
Long-Term Investments	8	17
Other measurement basis: | Nonmarketable investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Short-term investments	0	0
Long-Term Investments	4	5
Other measurement basis: | Cash on hand
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	743	801
Short-term investments	0	0
Long-Term Investments	$ 0	$ 0

Valuation of Debt and Equity _4

Valuation of Debt and Equity Investments and Certain Liabilities - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Credit losses related to available-for-sale investments	$ 0	$ 0	$ 0
Proceeds from sales, redemptions and maturities of short-term available-for-sale securities	11,190,000,000	13,390,000,000	$ 13,660,000,000
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Total assets fair value	0	0
Total liabilities fair value	$ 0	$ 0

Valuation of Debt and Equity _5

Valuation of Debt and Equity Investments and Certain Liabilities - Aggregate Maturities of Available-for-sale Debt Investments (Details) $ in Millions	Dec. 31, 2024 USD ($)
Fair Value Disclosures [Abstract]
One year or less	$ 5,348
One to two years	$ 727

Valuation of Debt and Equity _6

Valuation of Debt and Equity Investments and Certain Liabilities - Fair Value Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	$ 6,848	$ 7,786
Liabilities, fair value	443	393
Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	443	393
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	3,364	4,698
Liabilities, fair value	443	393
Level 1 | Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	443	393
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	3,484	3,088
Liabilities, fair value	0	0
Level 2 | Deferred compensation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities, fair value	0	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	762	1,068
Money market funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	762	1,068
Money market funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Corporate obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	1,490	1,954
Corporate obligations | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Corporate obligations | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	1,490	1,954
U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	4,237	4,504
U.S. government and agency securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	2,591	3,618
U.S. government and agency securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	1,646	886
Non-U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	348	248
Non-U.S. government and agency securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	0	0
Non-U.S. government and agency securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	348	248
Mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	11	12
Mutual funds | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	11	12
Mutual funds | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, fair value	$ 0	$ 0

Postretirement Benefit Plans -

Postretirement Benefit Plans - Additional Information (Details) - USD ($) shares in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit pension plan formula, highest consecutive years of compensation (in years)	5 years
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other income (expense), net (OI&E)	Other income (expense), net (OI&E)	Other income (expense), net (OI&E)
Length of time certain gains and losses are considered when determining the market-related value of assets related to the U.S. Qualified pension and retiree health care plans (in years)	3 years
Expected contribution to retirement benefit plans in next fiscal year	$ 10,000,000
Liability to participants of the deferred compensation plan	443,000,000
Deferred compensation plan assets	11,000,000
Defined Benefit | Equity investments
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets directly invested in TI common stock	0
Retiree Health Care | Equity investments
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets directly invested in TI common stock	$ 0
U.S.
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Number of company shares held by the U.S. defined contribution plans at year-end (in shares)	5	5
Value of the company shares held by the U.S. defined contribution plans at year-end	$ 852,000,000	$ 873,000,000
Dividends paid on the company shares held by the U.S. defined contribution plans at year-end	26,000,000	27,000,000
Aggregate expense for the U.S. defined contribution plans	76,000,000	75,000,000	$ 70,000,000
U.S. | Defined Benefit
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Accumulated benefit obligation	470,000,000	480,000,000
Non-U.S.
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Value of the company shares held by the non-U.S. retirement plans at year-end	34,000,000	34,000,000
Non-U.S. | Defined Benefit
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Accumulated benefit obligation	$ 1,470,000,000	$ 1,670,000,000
Defined contribution plan, also still accruing defined benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer matching contribution (percent)	2%
Enhanced defined contribution plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined contribution plan, employer matching contribution (percent)	4%
Defined contribution plan, employer fixed contribution (percent)	2%

Postretirement Benefit Plans _2

Postretirement Benefit Plans - Expense Related to Defined Benefit and Retiree Health Care Benefit Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 7	$ 8	$ 15
Interest cost	25	28	29
Expected return on plan assets	(23)	(23)	(27)
Amortization of prior service cost (credit)	0	0	0
Recognized net actuarial losses (gains)	4	6	3
Net periodic benefit costs (credits)	13	19	20
Settlement losses	1	7	64
Total, including other postretirement losses (gains)	14	26	84
U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Service cost	1	2	3
Interest cost	13	15	11
Expected return on plan assets	(16)	(19)	(12)
Amortization of prior service cost (credit)	0	0	(2)
Recognized net actuarial losses (gains)	(3)	(5)	0
Net periodic benefit costs (credits)	(5)	(7)	0
Settlement losses	0	0	0
Total, including other postretirement losses (gains)	(5)	(7)	0
Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Service cost	16	16	25
Interest cost	55	57	33
Expected return on plan assets	(77)	(63)	(66)
Amortization of prior service cost (credit)	1	1	1
Recognized net actuarial losses (gains)	11	12	1
Net periodic benefit costs (credits)	6	23	(6)
Settlement losses	0	0	10
Total, including other postretirement losses (gains)	$ 6	$ 23	$ 4

Postretirement Benefit Plans _3

Postretirement Benefit Plans - Benefit Obligations and Plan Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Change in plan assets
Funded status at end of year	$ 107	$ 53
U.S. | Defined Benefit
Change in plan benefit obligation
Benefit obligation at beginning of year:	505	521
Service cost	7	8	$ 15
Interest cost	25	28	29
Participant contributions	0	0
Benefits paid	(36)	(13)
Settlements	(2)	(40)
Actuarial loss (gain)	(6)	1
Effects of exchange rate changes	0	0
Benefit obligation at end of year	493	505	521
Change in plan assets
Fair value of plan assets at beginning of year:	418	421
Actual return on plan assets	18	47
Participant contributions	0	0
Benefits paid	(36)	(13)
Settlements	(2)	(40)
Effects of exchange rate changes	0	0
Other	0	0
Fair value of plan assets at end of year	400	418	421
Funded status at end of year	(93)	(87)
U.S. | Defined Benefit | Qualified Plan
Change in plan assets
Defined Benefit Plan, Plan Assets, Contributions by Employer	0	0
U.S. | Defined Benefit | Nonqualified Plan
Change in plan assets
Defined Benefit Plan, Plan Assets, Contributions by Employer	2	3
U.S. | Retiree Health Care
Change in plan benefit obligation
Benefit obligation at beginning of year:	258	274
Service cost	1	2	3
Interest cost	13	15	11
Participant contributions	13	14
Benefits paid	(39)	(41)
Settlements	0	0
Actuarial loss (gain)	(12)	(6)
Effects of exchange rate changes	0	0
Benefit obligation at end of year	234	258	274
Change in plan assets
Fair value of plan assets at beginning of year:	264	280
Actual return on plan assets	9	29
Participant contributions	13	14
Benefits paid	(39)	(41)
Settlements	0	0
Effects of exchange rate changes	0	0
Other	0	(19)
Fair value of plan assets at end of year	248	264	280
Funded status at end of year	14	6
U.S. | Retiree Health Care | Qualified Plan
Change in plan assets
Defined Benefit Plan, Plan Assets, Contributions by Employer	1	1
U.S. | Retiree Health Care | Nonqualified Plan
Change in plan assets
Defined Benefit Plan, Plan Assets, Contributions by Employer	0	0
Non-U.S. | Defined Benefit
Change in plan benefit obligation
Benefit obligation at beginning of year:	1,732	1,667
Service cost	16	16	25
Interest cost	55	57	33
Participant contributions	1	1
Benefits paid	(83)	(77)
Settlements	(6)	(6)
Actuarial loss (gain)	(106)	80
Effects of exchange rate changes	(87)	(6)
Benefit obligation at end of year	1,522	1,732	1,667
Change in plan assets
Fair value of plan assets at beginning of year:	1,866	1,822
Actual return on plan assets	27	137
Participant contributions	1	1
Benefits paid	(83)	(77)
Settlements	(6)	(6)
Effects of exchange rate changes	(99)	(13)
Other	0	0
Fair value of plan assets at end of year	1,708	1,866	$ 1,822
Funded status at end of year	186	134
Non-U.S. | Defined Benefit | Qualified Plan
Change in plan assets
Defined Benefit Plan, Plan Assets, Contributions by Employer	2	2
Non-U.S. | Defined Benefit | Nonqualified Plan
Change in plan assets
Defined Benefit Plan, Plan Assets, Contributions by Employer	$ 0	$ 0

Postretirement Benefit Plans _4

Postretirement Benefit Plans - Amounts Recognized on our Balance Sheet (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	$ 233	$ 173
Accrued expenses and other liabilities & other long-term liabilities	(16)	(12)
Underfunded retirement plans	(110)	(108)
Funded status at end of year	107	53
U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	0	0
Accrued expenses and other liabilities & other long-term liabilities	(10)	(5)
Underfunded retirement plans	(83)	(82)
Funded status at end of year	(93)	(87)
U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	16	8
Accrued expenses and other liabilities & other long-term liabilities	0	0
Underfunded retirement plans	(2)	(2)
Funded status at end of year	14	6
Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Overfunded retirement plans	217	165
Accrued expenses and other liabilities & other long-term liabilities	(6)	(7)
Underfunded retirement plans	(25)	(24)
Funded status at end of year	$ 186	$ 134

Postretirement Benefit Plans _5

Postretirement Benefit Plans - Schedule of Change in AOCI (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)
Defined benefit plan amounts recognized in other comprehensive income net actuarial loss portion roll forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	$ 207
Adjustments, net actuarial loss	(73)
Recognized within net income, net actuarial loss	(13)
Net actuarial losses of defined benefit plans adjustment, tax effect	(23)
Total change to AOCI, net actuarial loss	(63)
AOCI balance, net actuarial loss portion (net of taxes), period end	144
Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Prior Service Costs Portion Roll Forward
AOCI balance, net prior service cost (net of taxes), beginning of period	0
Adjustments, prior service cost	0
Recognized within net income, prior service cost	(1)
Tax effect, prior service cost	0
Total change to AOCI, prior service credit	(1)
AOCI balance, net prior service cost (net of taxes), period end	(1)
U.S. | Defined Benefit
Defined benefit plan amounts recognized in other comprehensive income net actuarial loss portion roll forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	62
Adjustments, net actuarial loss	(1)
Recognized within net income, net actuarial loss	(5)
Net actuarial losses of defined benefit plans adjustment, tax effect	(1)
Total change to AOCI, net actuarial loss	(5)
AOCI balance, net actuarial loss portion (net of taxes), period end	57
U.S. | Retiree Health Care
Defined benefit plan amounts recognized in other comprehensive income net actuarial loss portion roll forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	(24)
Adjustments, net actuarial loss	(5)
Recognized within net income, net actuarial loss	3
Net actuarial losses of defined benefit plans adjustment, tax effect	0
Total change to AOCI, net actuarial loss	(2)
AOCI balance, net actuarial loss portion (net of taxes), period end	(26)
Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Prior Service Costs Portion Roll Forward
AOCI balance, net prior service cost (net of taxes), beginning of period	0
Adjustments, prior service cost	0
Recognized within net income, prior service cost	0
Tax effect, prior service cost	0
Total change to AOCI, prior service credit	0
AOCI balance, net prior service cost (net of taxes), period end	0
Non-U.S. | Defined Benefit
Defined benefit plan amounts recognized in other comprehensive income net actuarial loss portion roll forward
AOCI balance, net actuarial loss portion (net of taxes), beginning of period	169
Adjustments, net actuarial loss	(67)
Recognized within net income, net actuarial loss	(11)
Net actuarial losses of defined benefit plans adjustment, tax effect	(22)
Total change to AOCI, net actuarial loss	(56)
AOCI balance, net actuarial loss portion (net of taxes), period end	113
Defined Benefit Plan Amounts Recognized In Other Comprehensive Income Prior Service Costs Portion Roll Forward
AOCI balance, net prior service cost (net of taxes), beginning of period	0
Adjustments, prior service cost	0
Recognized within net income, prior service cost	(1)
Tax effect, prior service cost	0
Total change to AOCI, prior service credit	(1)
AOCI balance, net prior service cost (net of taxes), period end	$ (1)

Postretirement Benefit Plans _6

Postretirement Benefit Plans - Plan Assets by Level Three Hierarchy (Details) - USD ($) $ in Millions		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		$ 400	$ 418	$ 421
U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		248	264	280
Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		1,708	1,866	$ 1,822
Other | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	257	418
Other | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	246	260
Other | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	1,190	1,707
Level 1 | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		92	0
Level 1 | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2	4
Level 1 | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		42	106
Level 2 | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		51	0
Level 2 | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Level 2 | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		476	53
Fixed income securities and cash equivalents | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		244	272
Fixed income securities and cash equivalents | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		198	210
Fixed income securities and cash equivalents | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		1,310	1,444
Fixed income securities and cash equivalents | Other | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	101	272
Fixed income securities and cash equivalents | Other | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	196	206
Fixed income securities and cash equivalents | Other | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	820	1,343
Fixed income securities and cash equivalents | Level 1 | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		92	0
Fixed income securities and cash equivalents | Level 1 | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		2	4
Fixed income securities and cash equivalents | Level 1 | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		15	49
Fixed income securities and cash equivalents | Level 2 | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		51	0
Fixed income securities and cash equivalents | Level 2 | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Fixed income securities and cash equivalents | Level 2 | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		475	52
Equity securities | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		156	146
Equity securities | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		50	54
Equity securities | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		398	422
Equity securities | Other | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	156	146
Equity securities | Other | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	50	54
Equity securities | Other | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	[1]	370	364
Equity securities | Level 1 | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Equity securities | Level 1 | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Equity securities | Level 1 | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		27	57
Equity securities | Level 2 | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Equity securities | Level 2 | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		0	0
Equity securities | Level 2 | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets		$ 1	$ 1
[1] Consists of bond index and equity index funds, measured at net asset value per share, as well as cash equivalents.

Postretirement Benefit Plans _7

Postretirement Benefit Plans - Weighted Average Assumptions Used (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
U.S. | Defined Benefit
Weighted average assumptions used to determine benefit obligations:
Discount rate (in percent)	5.55%	5.20%
Long-term pay progression (in percent)	3%	3%
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate (in percent)	5.21%	5.67%
Long term rate of return on plan assets (in percent)	6.10%	5.70%
Long-term pay progression (in percent)	3%	3.75%
U.S. | Retiree Health Care
Weighted average assumptions used to determine benefit obligations:
Discount rate (in percent)	5.65%	5.17%
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate (in percent)	5.17%	5.68%
Long term rate of return on plan assets (in percent)	6%	5.70%
Non-U.S. | Defined Benefit
Weighted average assumptions used to determine benefit obligations:
Discount rate (in percent)	3.76%	3.28%
Long-term pay progression (in percent)	3.14%	3.12%
Weighted average assumptions used to determine net periodic benefit cost:
Discount rate (in percent)	3.28%	3.45%
Long term rate of return on plan assets (in percent)	4.28%	3.50%
Long-term pay progression (in percent)	3.12%	3.03%

Postretirement Benefit Plans _8

Postretirement Benefit Plans - Weighted Average Allocations (Details)	Dec. 31, 2024	Dec. 31, 2023
Fixed income securities and cash equivalents | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	61%	65%
Fixed income securities and cash equivalents | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	80%	80%
Fixed income securities and cash equivalents | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	77%	77%
Fixed income securities and cash equivalents | Minimum | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	60%
Fixed income securities and cash equivalents | Minimum | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	75%
Fixed income securities and cash equivalents | Minimum | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	60%
Fixed income securities and cash equivalents | Maximum | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	75%
Fixed income securities and cash equivalents | Maximum | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	85%
Fixed income securities and cash equivalents | Maximum | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	100%
Equity securities | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	39%	35%
Equity securities | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	20%	20%
Equity securities | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Actual plan asset allocation (in percent)	23%	23%
Equity securities | Minimum | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	25%
Equity securities | Minimum | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	15%
Equity securities | Minimum | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	0%
Equity securities | Maximum | U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	40%
Equity securities | Maximum | U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	25%
Equity securities | Maximum | Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Targeted allocation (in percent)	40%

Postretirement Benefit Plans _9

Postretirement Benefit Plans - Assumed Future Benefits Payments (Details) $ in Millions	Dec. 31, 2024 USD ($)
U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
2025	$ 80
2026	76
2027	67
2028	60
2029	54
2030 – 2034	193
U.S. | Retiree Health Care
Defined Benefit Plan Disclosure [Line Items]
2025	25
2026	24
2027	23
2028	21
2029	21
2030 – 2034	92
Non-U.S. | Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
2025	85
2026	88
2027	88
2028	90
2029	92
2030 – 2034	$ 476

Postretirement Benefit Plans_10

Postretirement Benefit Plans - Health Care Cost Trend Rates (Details) - U.S. - Retiree Health Care	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Assumed health care cost trend rate for next year (in percent)	7%	7%
Ultimate trend rate (in percent)	5%	5%
Year in which ultimate trend rate is reached	2033	2032

Debt and Lines of Credit - Addi

Debt and Lines of Credit - Additional Information (Details)	1 Months Ended								12 Months Ended
	Nov. 30, 2024 USD ($)	May 31, 2024 USD ($)	Feb. 29, 2024 USD ($) series	May 31, 2023 USD ($) series	Mar. 31, 2023 USD ($)	Nov. 30, 2022 USD ($) series	Aug. 31, 2022 USD ($) series	Apr. 30, 2022 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2024 USD ($) series
Debt Instrument [Line Items]
Commercial paper									$ 0
Proceeds from issuance of long-term debt									2,980,000,000	$ 3,000,000,000	$ 1,494,000,000
Repayments of debt									600,000,000	500,000,000	500,000,000
Interest and debt expense									508,000,000	353,000,000	214,000,000
Interest paid									473,000,000	321,000,000	198,000,000
Interest costs capitalized									$ 20,000,000	$ 11,000,000	$ 6,000,000
Notes due 2027 at 4.60%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									4.60%
Notes due 2029 at 4.60%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									4.60%
Notes due 2034 at 4.85%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									4.85%
Notes due 2054 at 5.15%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									5.15%
Notes due 2024 at 2.625%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									2.625%
Repayments of debt		$ 300,000,000
Notes due 2024 at 4.70%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									4.70%
Repayments of debt	$ 300,000,000
Notes due 2028 at 4.60%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									4.60%
Notes due 2063 at 5.05%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									5.05%
Notes Due 2023 at 2.25%
Debt Instrument [Line Items]
Repayments of debt				$ 500,000,000
Notes due 2022 at 1.85%
Debt Instrument [Line Items]
Repayments of debt								$ 500,000,000
Notes due 2032 at 3.65%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									3.65%
Notes due 2052 at 4.10%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)									4.10%
Senior Notes
Debt Instrument [Line Items]
Number of series of debt issued | series			5	3		2	2					2
Principal amount			$ 3,000,000,000	$ 1,600,000,000		$ 800,000,000	$ 700,000,000					$ 1,400,000,000
Debt issuance costs			16,000,000	7,000,000		3,000,000	3,000,000					11,000,000
Proceeds from issuance of long-term debt			2,980,000,000	1,600,000,000	$ 1,400,000,000	799,000,000	695,000,000
Senior Notes | Notes due 2027 at 4.60%
Debt Instrument [Line Items]
Principal amount			$ 650,000,000
Long-term debt stated interest rate (in percentage)			4.60%
Senior Notes | Notes due 2029 at 4.60%
Debt Instrument [Line Items]
Principal amount			$ 650,000,000
Long-term debt stated interest rate (in percentage)			4.60%
Senior Notes | Notes due 2034 at 4.85%
Debt Instrument [Line Items]
Principal amount			$ 600,000,000
Long-term debt stated interest rate (in percentage)			4.85%
Senior Notes | Notes due 2054 at 5.15%
Debt Instrument [Line Items]
Principal amount			$ 750,000,000
Long-term debt stated interest rate (in percentage)			5.15%
Senior Notes | Notes due 2063 at 5.05%
Debt Instrument [Line Items]
Principal amount			$ 350,000,000
Long-term debt stated interest rate (in percentage)			5.05%
Senior Notes | Notes due 2024 at 4.70%
Debt Instrument [Line Items]
Principal amount						$ 300,000,000
Long-term debt stated interest rate (in percentage)						4.70%
Senior Notes | Notes due 2033 at 4.90%
Debt Instrument [Line Items]
Principal amount				$ 200,000,000								$ 750,000,000
Long-term debt stated interest rate (in percentage)				4.90%								4.90%
Senior Notes | Notes due 2053 at 5.00%
Debt Instrument [Line Items]
Principal amount												$ 650,000,000
Long-term debt stated interest rate (in percentage)												5%
Senior Notes | Notes due 2028 at 4.60%
Debt Instrument [Line Items]
Principal amount				$ 200,000,000		$ 500,000,000
Long-term debt stated interest rate (in percentage)				4.60%		4.60%
Senior Notes | Notes due 2063 at 5.05%
Debt Instrument [Line Items]
Principal amount				$ 1,200,000,000
Long-term debt stated interest rate (in percentage)				5.05%
Senior Notes | Notes due 2032 at 3.65%
Debt Instrument [Line Items]
Principal amount							$ 400,000,000
Long-term debt stated interest rate (in percentage)							3.65%
Senior Notes | Notes due 2052 at 4.10%
Debt Instrument [Line Items]
Principal amount							$ 300,000,000
Long-term debt stated interest rate (in percentage)							4.10%
Revolving credit facility
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity									$ 1,000,000,000

Debt and Lines of Credit - Sche

Debt and Lines of Credit - Schedule of Long-term Debt Outstanding (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total debt	$ 13,700	$ 11,300
Net unamortized discounts, premiums and issuance costs	(104)	(77)
Total debt, including net unamortized discounts, premiums and issuance costs	13,596	11,223
Current portion of long-term debt	(750)	(599)
Long-term debt	$ 12,846	10,624
Notes due 2024 at 2.625%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.625%
Total debt	$ 0	300
Notes due 2024 at 4.70%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.70%
Total debt	$ 0	300
Notes due 2025 at 1.375%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.375%
Total debt	$ 750	750
Notes due 2026 at 1.125%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.125%
Total debt	$ 500	500
Notes due 2027 at 4.60%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.60%
Total debt	$ 650	0
Notes due 2027 at 2.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.90%
Total debt	$ 500	500
Notes due 2028 at 4.60%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.60%
Total debt	$ 700	700
Notes due 2029 at 4.60%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.60%
Total debt	$ 650	0
Notes due 2029 at 2.25%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.25%
Total debt	$ 750	750
Notes due 2030 at 1.75%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.75%
Total debt	$ 750	750
Notes due 2031 at 1.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	1.90%
Total debt	$ 500	500
Notes due 2032 at 3.65%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	3.65%
Total debt	$ 400	400
Notes due 2033 at 4.90%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.90%
Total debt	$ 950	950
Notes due 2034 at 4.85%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.85%
Total debt	$ 600	0
Notes due 2039 at 3.875%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	3.875%
Total debt	$ 750	750
Notes due 2048 at 4.15%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.15%
Total debt	$ 1,500	1,500
Notes due 2051 at 2.70%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	2.70%
Total debt	$ 500	500
Notes due 2052 at 4.10%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	4.10%
Total debt	$ 300	300
Notes due 2053 at 5.00%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	5%
Total debt	$ 650	650
Notes due 2054 at 5.15%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	5.15%
Total debt	$ 750	0
Notes due 2063 at 5.05%
Debt Instrument [Line Items]
Long-term debt stated interest rate (in percentage)	5.05%
Total debt	$ 1,550	$ 1,200

Leases - Component of Balance S

Leases - Component of Balance Sheet Information Related to Leases (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Other long-term assets	$ 786	$ 579
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other long-term assets	Other long-term assets
Accrued expenses and other liabilities	$ 118	$ 88
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued expenses and other liabilities	Accrued expenses and other liabilities
Other long-term liabilities	$ 663	$ 478
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other long-term liabilities	Other long-term liabilities

Leases - Schedule of Operating

Leases - Schedule of Operating Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Lease cost related to lease liabilities	$ 85	$ 73	$ 67
Variable lease cost	64	54	46
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for lease cost	65	65	61
Lease assets obtained in exchange for new lease liabilities	$ 241	$ 285	$ 37

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
2025	$ 121
2026	114
2027	103
2028	92
2029	80
Thereafter	489
Total	999
Imputed lease interest	(218)
Total lease liabilities	$ 781
Weighted average remaining lease term	10 years 9 months 18 days	11 years 8 months 12 days
Weighted average discount rate	4.53%	4.22%

Commitments and Contingencies_2

Commitments and Contingencies (Details) $ in Millions	Dec. 31, 2024 USD ($)
Purchase commitments
2025	$ 463
2026	317
2027	263
2028	135
2029	135
Thereafter	104
Total	$ 1,417

Supplemental Financial Inform_3

Supplemental Financial Information - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disclosure Text Block Supplement [Abstract]
Restructuring charges/other	$ (124)	$ 0	$ 257

Supplemental financial inform_4

Supplemental financial information - Other income (expense), net (OI&E) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disclosure Text Block Supplement [Abstract]
Other income	[1]	$ 534	$ 483	$ 169
Other expense	[2]	(38)	(43)	(63)
Total		$ 496	$ 440	$ 106
[1]ncludes interest, royalty and lease income.[2]ncludes a portion of pension and other retiree benefit costs, lease expense, tax interest, currency gains and losses and miscellaneous items.

Supplemental Financial Inform_5

Supplemental Financial Information - Prepaid expenses and other current assets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Disclosure Text Block Supplement [Abstract]
CHIPS Act incentives	$ 904	$ 497
Other	296	264
Total	$ 1,200	$ 761

Supplemental financial inform_6

Supplemental financial information - Property, plant and equipment at cost (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	$ 15,254	$ 13,268
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	113	150
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	$ 6,424	5,549
Buildings and improvements | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	40 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost	$ 8,717	$ 7,569
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	5 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Property, plant and equipment at cost, depreciable lives	10 years

Supplemental financial inform_7

Supplemental financial information - Schedule of Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill [Line Items]
Goodwill	$ 4,362	$ 4,362
Goodwill impairment loss	0	0	$ 0
Analog
Goodwill [Line Items]
Goodwill	4,158	4,158
Embedded Processing
Goodwill [Line Items]
Goodwill	172	172
Other
Goodwill [Line Items]
Goodwill	$ 32	$ 32

Supplemental Financial Inform_8

Supplemental Financial Information - Other long term assets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Disclosure Text Block Supplement [Abstract]
CHIPS Act incentives	$ 2,246	$ 859
Other	1,102	853
Total	$ 3,348	$ 1,712

Supplemental financial inform_9

Supplemental financial information - Accrued expenses (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Disclosure Text Block Supplement [Abstract]
Accrued capital-related expenditures	$ 352	$ 341
Other	723	570
Total	$ 1,075	$ 911

Supplemental financial infor_10

Supplemental financial information - Accumulated other comprehensive income (loss), net of taxes (AOCI) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	$ 16,903	$ 16,897
AOCI
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	(140)	(205)	$ (254)	$ (157)
Net actuarial loss
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	(144)	(207)
Prior service credit
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	1	0
Unrealized gains on available-for-sale investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	2	2
Derivative instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total	$ 1	$ 0

Supplemental financial infor_11

Supplemental financial information - Amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)		$ 496	$ 440	$ 106
Provision for income taxes		(654)	(908)	(1,283)
Net income		4,799	6,510	8,749
Reclassification out of Accumulated Other Comprehensive Income | Net actuarial losses of defined benefit plans:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)	[1]	13	20	78
Provision for income taxes		(3)	(5)	(17)
Net income		10	15	61
Reclassification out of Accumulated Other Comprehensive Income | Prior service cost (credit) of defined benefit plans:
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other income (expense), net (OI&E)	[1]	1	1	(1)
Provision for income taxes		0	0	0
Net income		$ 1	$ 1	$ (1)
[1] Detailed in Note 7